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Polyunsaturated fatty acids (PUFA) affect key cellular and physiological processes in the body 
ranging from cell signalling to inflammation. Compositional, dietary refinement and bioassay 
studies have shown strong associations between the PUFA composition of skeletal muscle with 
various contractile properties as well as the development of obesity and insulin resistance. 
Relatively little is known about the uptake and incorporation of PUFA in skeletal muscle, 
especially in regards to fibre type-specific properties. The incorporation of PUFAs into rat soleus 
(slow-twitch oxidative), red gastrocnemius (fast-twitch oxidative), and white gastrocnemius 
(fast-twitch glycolytic) muscle were examined using stable isotope-labelled fatty acids and a 
novel internal isobutane positive chemical ionization (PCI) gas chromatography-mass 
spectrometry (GC-MS) technique. Two separate tracer studies were conducted.  In the first study, 
four groups of rats were orally dosed by gavage with one of three isotopes of 18:2n-6; 
13
C18-
18:2n-6 ethyl ester, 
13
C18-18:2n-6 nonesterified fatty acid or 
2
H5-18:2n-6 ethyl ester and a control 
group received the vehicle only (olive oil). Animals were sacrificed 8 hours post dosing and 
soleus, red and white gastrocnemius muscles were collected for lipid analysis. In the second 
study, rats were orally administered a single dose of a mixture of 4 isotopes (0.15 mg/g body 






C16-16:0, and nonesterified 
2
H2-
18:1n-9) or vehicle only (olive oil) as a control.  Groups of animals were sacrificed at 8, 24, and 
48 h after dosing and four muscle types (heart, soleus, red and white gastrocnemius) were 
collected and analyzed for isotopic signal of these fatty acids and their corresponding 
desaturation and/or elongation products.  Soleus accumulated the most 18:2n-6 and 18:3n-3 
followed by red gastrocnemius and white gastrocnemius.  Soleus also accumulated significantly 
iv 
higher concentrations of labelled n-6 fatty acids derived from 18:2n-6 in both studies. Heart 
muscle accumulated 20:5n-3 and 22:6n-3 increasingly over time while skeletal muscle 
accumulation was variable across fibre types.  Labelled 20:5n-3 was detected in red and white 
gastrocnemius at 8 and 24 hr with levels declining by 48 h while no 20:5n-3 was detected in 
soleus at anytime.  Labelled 22:6n-3 was not detected in white gastrocnemius, but 22:6n-3 
appeared to be increasing in red gastrocnemius over time.  Soleus demonstrated a large 
accumulation of 22:6n-3 at 8 h with no detectable levels at 48 h.  In conclusion, we were able to 
demonstrate that the distribution and metabolism of various PUFAs differ in muscle types with 
distinct fibre type composition using a novel internal isobutane PCI GC MS method.  Further 
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Polyunsaturated fatty acids (PUFA) are required for a wide range of physiological 
functions. The best characterized among them are the functions of eicosanoids that are 
enzymatically synthesized from PUFA and work as autocrine/paracrine hormones mediating a 
variety of functions such as immune response, blood pressure regulation, and blood coagulation 
(Samuelsson, 1983). Recent studies have uncovered further involvement of PUFA in 
fundamental cellular functions, including endocytosis/exocytosis (Schmidt et al., 1999), ion 
channel modulation (Leaf and Kang, 1996) and regulation of gene expression (Clarke and Jump, 
1994). Although many studies have focused upon the liver as the primary site for PUFA 
metabolism in mammals, relatively little is known about other organs with respect to their uptake 
of PUFA or the manner in which these fatty acids are distributed to them. Thus, the recent 
studies on PUFA metabolism have shifted their attention away from liver towards other organs 
such as heart, kidney, liver, brain, testes and skeletal muscle (Bourre et al., 1990; Fu, Attar-
Bashi, and Sinclair, 2001; Lin and Salem, Jr., 2007; DeMar, Jr. et al., 2008). The PUFA 
composition of skeletal muscle has been associated with various contractile properties (Ayre and 
Hulbert, 1996) and may play a role in improving obesity and insulin resistance (Kuda et al., 
2009; Rossmeisl et al., 2009; Shimura et al., 1997). However, PUFA tracer studies in skeletal 
muscle (Lin and Salem, Jr., 2007; DeMar, Jr. et al., 2008) have provided us with fragmented 
information regarding muscle type differences in PUFA uptake and metabolism. The present 
thesis investigates how linoleate, linolenate and their major metabolites, are absorbed, distributed 
and retained in various muscle types (i.e. slow and fast twitch). To accomplish this purpose two 
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different approaches were followed; 1) a characterization in which the fatty acid compositions of 
the muscle types were systematically compared particularly with regard to their PUFA content, 
2) a prospective approach through which the distribution of the isotopic labelled precursors and 
their major in vivo metabolites were followed among various muscle types after experimental 
animals were ingested with a single bolus of the labelled precursors. 
 
BIOCHEMICAL AND PHYSIOLOGICAL FOUNDATIONS 
1.1 Fatty Acids 
1.1.1 Overview 
Fatty acids are compounds synthesised in nature via condensation of a malonyl coenzyme 
A (COOH-CH2-CO-S-CoA) unit by a fatty acid synthase complex. In general, fatty acids contain 
even numbers of carbon atoms in straight chains (only occasionally outside the range of C14 to 
C24) with a carboxyl group at one extremity and with double bonds of cis (or Z) configuration. 
Based on the hydrocarbon chain length, fatty acids have been divided into four groups; short 
chain fatty acids (≤ 6 carbons), medium chain fatty acids (8-12 carbons), long chain fatty acids 
(14-22 carbons), and very long chain fatty acids (>22 carbons). Fatty acids from animal tissues 
may have zero to six double bonds which are specified in systematic nomenclature in relation to 
the carboxyl group. Depending on the number of carbon-carbon double bonds, fatty acids are 
categorized as saturated (0), monounsaturated (1), and polyunsaturated (>1). The term HUFA 
(highly unsaturated fatty acids) has recently begun to be used in the literature to identify PUFAs 
with 3 double bonds and  20 carbons as this group of fatty acids have important structural and 
physiological roles (Nakamura et al., 2001). 
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1.1.2 Polyunsaturated fatty acids (PUFA) 
PUFAs have two or more double bonds and are typically 18–22 carbon atoms long 
consisting of the omega-6 and omega-3 families of fatty acids, otherwise known as the n-6 and 
n-3 fatty acids. The n-6 and n-3 fatty acids differ from each other structurally by the position of 
their double bond from the methyl terminus (i.e. the “omega” end) at the 6th and the 3rd bond, 
respectively. They also differ functionally from each other and are not interconvertible, although 
they share and compete for several enzymes in their metabolic pathways (See Figure 1).  
Linoleic acid (LA; 18:2n-6) and alpha-linolenic acid (ALA; 18:3n-3) are considered as precursor 
fatty acids for the n-6 and n-3 families, respectively, as both LA and ALA can be further 
metabolized to HUFAs by the actions of delta-6 and delta-5 desaturases and elongase enzymes in 
tissues (Igarashi et al., 2007; Jump, 2002; Harris et al., 2008). These fatty acids each undergo 
three rounds of desaturation and three rounds of elongation, followed by β-oxidation to produce 
the final products 22:5n-6 and 22:6n-3 (Igarashi et al., 2007) (See Figure 1). LA and ALA are 
known as essential fatty acids in mammals as they cannot be synthesized de novo and they are 
required in the diet to prevent deficiencies (Pudelkewicz, Seufert, and Holman, 1968).  In plants, 
algae and some bacteria, LA is synthesized by the action of delta-12 desaturase, which forms a 
double bond, six positions from the methyl end of 16- and 18-carbon monounsaturated fatty 
acids.  This linoleic acid product can be further desaturated by delta-15 desaturase, which forms 
a double bond, three positions from the methyl end forming ALA (Morimoto et al., 2005).  
Important dietary sources of LA include vegetable oils such as corn oil, and those of ALA 
include green leaves and some oils such as flaxseed and canola oil (Burdge and Calder, 2005). 
Arachidonic aid (AA; 20:4n-6) and docosahexaenoic acid (DHA; 22:6n-3) are the major in vivo 




Figure 1. Polyunsaturated fatty acid biosynthetic pathway. LA: linoleic acid (18:2n-6); ALA: α-
linolenic acid (18:3n-3); AA: arachidonic acid (20:4n-6); EPA: eicosapentaenoic acid (20:5n-3); 
DHA: docosahexaenoic acid (22:6n-3). Adapted from (Harris et al., 2008) 
 
 
efficiencies of LA to AA, and ALA to DHA have been reported to be low with estimates of 1.4 
% of dietary ALA and 3 % of dietary LA being converted to long-chain PUFAs in rats (Cunnane 
and Anderson, 1997b). AA is particularly important as the main component of membrane 
phosphoslipids, and as a precursor of the prostaglandins and other eicosanoid metabolites. DHA 
is particularly enriched in the phospholipids of cells constituting the mammalian nervous system 
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and consequently important for cognitive function and vision maturity and resolution (Carlson 
and Neuringer, 1999; SanGiovanni et al., 2000). Functionally, DHA enhances membrane 
elasticity and molecular motion and thus promotes signal transduction via enhanced 
protein/receptor interactions (Gawrisch, Eldho, and Holte, 2003). DHA can also serve as an 
activating ligand for multiple transcriptional factors that control the expression of enzymes 
involved in fatty acid synthesis and β-oxidation (Clarke and Jump, 1994). As one of the n-3 
precursors for the eicosanoid production, DHA contributes to protection against inflammation 
and cardiovascular diseases (Calder, 2004). 
1.1.3 Mechanism of fat digestion and absorption 
The first step of fat digestion occurs in the stomach and is catalyzed by lingual or gastric 
lipase. The major digestion products of this gastric phase are diacylglycerol and nonesterified 
fatty acids (NEFA) (Thomson et al., 1989). Pancreatic lipase cleaves fatty acids at the sn-1 and 
sn-3 position of triacylglycerols yielding to 2-monoglycerides (2-MG) and NEFA (Carlier, 
Bernard, and Caselli, 1991). Dietary phospholipids are hydrolyzed by activated pancreatic 
phospholipase A2 yielding to 1-lysophospholipids and NEFA (Carlier, Bernard, and Caselli, 
1991). The major products of lipid digestion, NEFA and 2-MG enter the enterocyte by simple 
diffusion across the plasma membrane. A considerable fraction of the fatty acids also enter the 
enterocyte via a specific fatty acid transporter protein in the membrane (Luiken et al., 2001). 
Absorbed lipids are re-esterified to form triacylglycerols (TG) and phospholipids (PL) in the 
smooth endoplasmic reticulum in the intestinal brush border. TGs, PLs, cholesterol and 
apoproteins are used to synthesize chylomicrons, which are secreted to the lymph and then to the 
general blood stream through the thoracic duct. In extra-hepatic tissues, the TG content of 
chylomicrons is hydrolysed in the capillaries by lipoprotein lipase attached to the outside of the 
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cells lining the blood capillaries to produce glycerol and NEFA which enter the adjacent cells. 
The amount of lipase activity present in the capillaries of a particular tissue determine the 
amount of NEFA release in that tissue and insulin can stimulate the lipase activity (Voet and 
Voet, 2004).   
1.1.4 Effects of fatty acid chain length and saturation  
Unsaturated fatty acids and medium chain fatty acids (MCFAs) are more efficiently 
absorbed than long-chain saturated fatty acids. Because of the way that MCFA are digested, they 
can be absorbed in the stomach, after hydrolysis of medium chain TG by gastric lipase 
(Christensen et al., 1995), and can also be solubilized in the aqueous phase of the intestinal 
contents, where they are absorbed bound to albumin and transported to the liver via the portal 
vein (Decker, 1996). With increasing chain lengths of saturated fatty acids, an increasing 
proportion is absorbed into the lymphatic pathway and a decreasing proportion is absorbed by 
way of the portal venous blood (Thomson et al., 1989). 
1.1.5 Fat oxidation 
The first stage in oxidation of fatty acids is to convert the NEFA to a fatty acyl-CoA 
compound, a reaction known as fatty acid activation. Activated fatty acids are subsequently 
broken down by removing two carbon atoms at a time as acetyl-CoA, a process known as β-
oxidation. Activation of fatty acids occurs in the outer mitochondrial membrane but their 
conversion to acetyl-CoA occurs only in the mitochondrial matrix. The acyl group of fatty acyl-
CoA is carried through the inner mitochondrial membrane, without the CoA, by a special 
transport mechanism (i.e. carnitine cycle) then handed over to CoASH in the mitochondrial 
matrix to become fatty acyl-CoA again. Long-chain fatty acids (LCFA) which encompass 
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PUFAs enter the mitochondrial space via the carnitine cycle, whereas short- and medium-chain 
fatty acids enter directly in their protonated form (Christie, 1989) (See Figure 2).  
1.1.6 β-oxidation 
The reaction sequence in each round of the β-oxidation involves conversion of β carbon 
atom (i.e. the third carbon from carboxyl end) to a C=O group, forming a β-ketoacyl-CoA 
through reduction, oxidation and reduction reactions.  The ketoacyl-CoA is cleaved by CoASH, 
splitting off two carbon atoms as acetyl-CoA and forming a shorter fatty acyl-CoA derivative. 
Oxidation of unsaturated fatty acids requires an isomerase reaction to position existing double 
bonds on the normal metabolic path of β-oxidation (Christie, 1989).  
1.1.7 Peroxisomal oxidation  
In animal cells, mitochondria and peroxisomes oxidize fatty acids via β-oxidation. The 
major differences between peroxisomal and mitochondrial β-oxidation include; different 
substrate specificities, transport of substrates and products of β-oxidation across the membrane. 
Short and medium-chain fatty acids are exclusively, and long-chain fatty acids are predominantly 
oxidized in mitochondria, whereas very long-chain fatty acids, notably 26:0, can only be handled 
by peroxisomes.  Peroxisomal oxidation of fatty acids does not generate ATP (Wanders and 
Waterham, 2006). 
1.2 Skeletal Muscle and Fatty Acids 
1.2.1 Skeletal muscle diversity  
One of the unique features of skeletal muscle is its composition of a large number of 
different types of muscle fibres which contribute to a variety of functional capabilities present in 
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skeletal muscle. These fibre types can differ and be categorized according to their molecular, 
metabolic, structural and contractile properties. The diversity of the skeletal muscle was 
recognized as early as 1873 when Ranvier categorized red muscles with slow contraction and 
white muscles with fast muscle contraction based upon appearance and stimulation of the muscle 
with electrical current (Ranvier, 1873). Various fibre type classification schemes were developed 
but only a few are widely used. To date, the most useful schemes to delineate fibre types are 
based on histochemical and electrophoretic differences in myosin ATPase activity of myosin 
heavy chain (MHC) isoforms (Staron and Pette, 1986). According to the major MHC isoforms 
found in the adult mammalian skeletal muscles, the following pure fibre types can be delineated; 
slow type I with MHCIβ, slow cardiac MHC isoform, and three fast types, namely type IIA with 
MHC isoform IIa, type IID with MHCIId, and type IIB with MHCIIb, while MHCIId and fibre 
type IID are considered to be equivalent to MHCIIx and fibre type IIX, respectively (Pette and 
Staron, 1990; Schiaffino and Reggiani, 1994). Both nomenclatures, therefore, coexist in the 
literature. Comparative studies on various mammals have revealed that as body mass increases, 
expression levels of the slower MHC isoforms increase at the expense of faster isoforms (Aigner 
et al., 1993; Hamalainen and Pette, 1995). For instance, it was shown that type IIB fibres 
comprise 71% of the total mass of the muscle in rats followed by type IID/X 18% , type IIA 5% 
and type I 6% (Delp and Duan, 1996), while muscle in human and other large mammals do not 
appear to express MHCIIb. Fibres previously classified as type IIB in human muscle have 
therefore been renamed type IIX or type IID, based on their MHC complement that resembles 
MHCIIx (MHCIId) of the rat. Some of the most important functional and morphological 
properties of the MHC-based fibre types are summarized in Table 1. It has been shown that the 
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oxidative potential of rat muscle is greatest when composed of type IIA fibres and in the rank 
order of type IIA > I > IID/X > IIB fibres (Delp and Duan, 1996).  
Table 1. Common classification of skeletal muscle fibre types and fibre type percentages in the  




Contractile speed Slow-twitch Fast-twitch Fast-twitch Fast-twitch 
Myosin heavy chain Type I Type IIA Type IIX/D Type IIB 
Metabolic Oxidative Oxidative-glycolytic Glycolytic  Glycolytic 
Anatomical (color) Red Red White White 
Fibre CSA Small Medium Large Large 
 
 
Average % in V. Lateralis 
Human
1 




  1 36 n/d 63 
Mouse
3
  0 30 n/d 70 
1
Humans do not typically express IIB myosin heavy chain in the locomotor skeletal muscles 
(Andersen, Schjerling, and Saltin, 2000; Smerdu et al., 1994). 
2
Rat (Armstrong and Phelps, 
1984) and 
3
mouse (Burkholder et al., 1994) did not delineate the fast fibre types into IIX and IIB 
subtypes, therefore IIX and IIB subtypes are likely combined in the IIX fibre data. CSA, cross 
sectional area; n/d, not detected. Adapted from (Spangenburg and Booth, 2003). 
1.2.2 Fat transport across muscle membrane  
Movement of fatty acids from the interstitium across the plasma membrane differs for 
short and medium chain fatty acids, relative to long and very long chain fatty acids. Transport of 
short and medium chain fatty acid into muscle and across mitochondrial membranes is fully 
dependent on passive diffusion dictated by the concentration or driving gradient of these fatty 
acids. This phenomenon is known as “flip-flop” and involves a number of discrete and sequential 
steps including; movement of fatty acids to the outer leaflet of the phospholipid bilayers, 
insertion into the outer phospholipid bilayers, flip-flop across the membrane, dissociation from 
the inner phospholipid bilayers, and rendering the fatty acid inside the cell or mitochondrial 
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matrix (Noy, Donnelly, and Zakim, 1986). For LCFA which encompass all PUFAs, fatty acid 
transport into muscle and subsequently into mitochondrial matrix occurs largely through a highly 
regulated protein-mediated mechanism involving a number of fatty acid transporters. Three types 
of transport proteins have been identified; a fatty acid binding protein (FABPpm) located on the 
outer leaflet of the plasma membrane, a family of fatty acid transport proteins (FATP1–6) that 
have at least six transmembrane domains, and a highly glycosolated fatty acid translocase 
(FAT/CD36) (FAT is the homologue of human CD36) that has at least 2 transmembrane 
domains (Abumrad, Coburn, and Ibrahimi, 1999). FABPpm and FAT/CD36 are expressed in 
proportion to the rate of LCFA oxidation in muscle tissues (heart >> red muscle >> white 
muscle) (Bonen et al., 1998; Chabowski et al., 2006). Studies using confocal 
immunofluorescence microscopy (Keizer et al., 2004) have shown that FAT/CD36 and FABPpm 
are harboured at the level of the plasma membrane and in an intracellular depot. Similar to the 
glucose uptake by skeletal muscle, LCFA transport can also be regulated within minutes by 
muscle contraction, AMP-activated protein kinase activation, leptin, and insulin (Nickerson et 
al., 2007) through the induction of the translocation of FAT/CD36 (Bonen et al., 2000; 
Chabowski et al., 2005) and FABPpm (Chabowski et al., 2005; Han et al., 2007) from their 
intracellular depot to the plasma membrane. It has been hypothesized that in insulin-resistant 
muscle, a permanent relocation of FAT/CD36 to the sarcolemma may account for the excess 
accretion of intracellular lipids that interfere with insulin signalling. Inside the cell, LCFA 
remain water insoluble and are bound to FABPc or acyl-CoA binding protein. It has been 
suggested that FABPc likely works in a concerted fashion with FAT/CD36 to transport LCFA 
across the plasma membrane (Luiken et al., 1999). A schematic diagram of fatty acid 
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transportation across sarcolemma into muscle and subsequently into mitochondria is presented in 
Figure 2.  
Figure 2. Fatty acid uptake in skeletal 
muscle and oxidation in mitochondria. 
LCFA: long chain fatty acid; SCFA: short 
chain fatty acid; MCFA: medium chain 
fatty acid; CPTI: Carnitine palmitoyl 
transferases I; FABPpm: Fatty acid binding 
protein pm; FAT: fatty acid translocator; 
FABPc: Fatty acid binding protein c. 










1.2.3 Fat metabolism in skeletal muscle 
Fatty acids originating from chylomicrons and very-low-density lipoproteins are 
hydrolyzed by lipoprotein lipase (LPL) and subsequently are taken up by muscle, esterified in 
the sacroplasmic reticulum to triacylglycerol, and incorporated into lipid droplets in muscle 
(Figure 3). It has been shown that in the postprandial state there is a clear preferential uptake of 
fatty acids derived from LPL-mediated chylomicron hydrolysis into skeletal muscle as compared 
with plasma NEFAs or very-low density lipoprotein derived fatty acids (Bickerton et al., 2007; 
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Evans et al., 2002). This suggests higher absorption of dietary fatty acid or those ingested 
compared to those being delivered intravenously. Most fatty acids entering muscle cells from 
circulation are rapidly esterified to TGs (70-90%), with the remaining fatty acids being 
maintained in a NEFA pool. During muscle contraction, fatty acids are predominantly derived 
from the adipose tissue and intramuscular TG (Kiens, Roemen, and van der Vusse, 1999). 
Lipolysis in adipose tissue and in intramuscular TG is regulated by a hormone sensitive lipase 
(HSL) which is activated by beta-adrenergic receptors (Coyle, 1999). It appears that the two 
lipases (i.e. LPL and HSL) function as a coordinated unit in meeting the energy demands of 
muscle. Both LPL and HSL are regulated, in part, through the classic cAMP cascade in muscle. 
However, the functions of these lipases are different. While activation of HSL results in the 
hydrolysis of intracellular TG, providing fatty acids for β oxidation, the exported LPL found in 
the capillary beds hydrolyzes circulating TG, providing fatty acids for the replenishment of lipid 
stores and, to a lesser extent, immediate substrate for muscle energy needs. The activities of LPL 
and HSL are the highest in the soleus, lower in the red portion of gastrocnemius, and 
undetectable in the white portion of gastrocnemius (Smol et al., 2001). However, removing the 
normally high level of postural support by red oxidative muscles (i.e. Type I and Type IIA) can 
abolish up to 95% of LPL activity differences between muscle fibre types (Oscai, Essig, and 
Palmer, 1990). This suggests that the difference in LPL activity between fibre types is primarily 
due to the level of recruitment in normal daily activity rather than intrinsic factors such as 





Figure 3. Muscle fatty acid metabolism and proposed mechanism for regulation of hormone-
sensitive lipase (HSL) and lipoprotein lipase (LPL). VLDL; very low density lipoprotein, 
Chylom; chylomicron, TG; triacylglycerols, NEFA; nonesterified fatty acids, cAMP; cyclic 
adenosine monophosphate.    
1.2.4 Effect of PUFA on muscle function  
A number of studies have shown that a high-fat diet can dramatically increase exercise 
performance in rats (Miller, Bryce, and Conlee, 1984; Simi et al., 1991) and humans (Lambert et 
al., 1994; Muoio et al., 1994). However exercise (resistance or endurance) is a multifactorial 
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phenomenon in which the observed effects of dietary changes may reflect changes in the 
respiratory and/or cardiovascular systems rather than on the muscles themselves. Therefore, 
study designs with higher level of specificity are required to elucidate the role of PUFAs on 
muscle function. The effects of manipulating dietary levels of essential PUFAs on several 
aspects of muscle function (i.e. single muscle twitch, sustained tetanic contractions, posttetanic 
potentiation, sustained high-frequency stimulation, and intermittent low-frequency stimulation) 
were examined in rats using in vitro preparations of extensor digitorum longus (EDL; fast twitch) 
and soleus (slow twitch) muscles (Ayre and Hulbert, 1996). Rats fed a PUFA-deficient diet 
relative to PUFA enriched diets had significantly lower muscular tensions and reduced response 
times with twitch contraction and half relaxation times significantly reduced by 5-7%.  Also, 
with the PUFA-deficient diet, peak twitch tension in soleus muscles was 16-21% less and EDL 
muscles fatigued 32% more quickly.  These differences disappeared once PUFAs were added to 
the deficient diet and the pattern of recovery of muscle performance mirrored the pattern of 
changes in the muscle phospholipid composition.   
Because phospholipids are the major structural lipid in membranes, changes in the dietary 
fatty acid profile could also have profound effects on membrane physical properties. For 
example, essential PUFAs deficiency may affect the fluidity of membranes (McMurchie, 1988) 
and therefore possibly exert influence over specific membrane proteins, such as enzymes 
(Murphy, 1990), or have a controlling influence on transport of small molecules across cell 
membranes (Sahlin et al., 1981). Consistent with these observations, 3 wks of supplementation 




 ATPase enzymes in isolated 
soleus muscles (Early and Spielman, 1995). Furthermore, phosphatidylserine and 
phosphatidylglycerol, two phospholipids generally high in PUFAs, have shown to stimulate this 
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enzyme to a greater extent than do phosphatidylinositol, phosphatidylethanolamine, 
phosphatidylcholine or diphosphatidylglycerol (Wheeler, Walker, and Barker, 1975). 




ATPase activity in response to changes in phospholipid 
content may more reflect changes in the PUFA content of the membrane.  
In a retrospective study, the fatty acid composition of high-frequency contraction muscles 
in hummingbirds (i.e. pectoral muscles) and rattlesnakes (i.e. shaker muscles) were compared 
with other muscles in the same species known to have much lower contraction frequency (i.e. leg 
muscles and ventral muscles, respectively) (Infante, Kirwan, and Brenna, 2001).  The 
concentration of 22:6n-3 was 20.8% in hummingbird pectoral muscles versus 4.9% for the low 
contraction frequency leg muscles and 15.1% in rattler muscles in rattlesnakes versus 10.6% for 
lower contraction frequency ventral muscles. The dramatic differences in the 22:6n-3 
concentrations between high and low frequency contraction muscles in the same species suggest 
that in high-frequency contraction muscles, 22:6n-3 enriched phospholipids are required to 
support the optimal functioning of ion pump activity of sarcoplasmic reticulum Ca
2+-
ATPase 
(SERCA) and electron transport in the mitochondria (Infante, Kirwan, and Brenna, 2001). In 
both, sarcoplasmic reticulum and mitochondria, PLs consist of approximately 80% of total lipids 
with TG being the dominant neutral lipid and both fractions have similarly high percentages of 
22:6n-3(approximately 20%) (Fiehn et al., 1971). The 22:6n-3-containing PL species are the 
most abundant PL species in rat sarcoplasmic reticulum (Fiehn et al., 1971) and the fact that 
SERCA represents approximately 90% of the total sarcoplasmic reticulum protein in fully 
differentiated skeletal muscle (MacLennan and Holland, 1975; Fiehn et al., 1971) further 




1.2.5 Muscle structural lipids and fatty acids 
Membrane PLs are the major structural lipids accounting for approximately 75% of total 
lipids in the skeletal muscle (Blackard et al., 1997).  All six PL species presented in the skeletal 
muscle are listed here in the order of their abundance in the skeletal muscle; 
phosphatidylcholine, phosphatidylethanolamine, cardiolipin, sphingomyelin, phosphatidylserine, 
and phosphatidylinositol (see Figure 4 for chemical structures). Phosphatidylcholine and 
phosphatidylethanolamine make up over 70% of the total PLs. These PL species serve as the 
main reserve of PUFAs, either for the short-time regeneration of PUFAs that have been degraded 
during membrane stimulation or for substrates for a variety of signalling molecules. It is difficult 
to use dietary manipulation to alter the ratio of saturated to unsaturated fatty acids in membrane 
PLs because of the biochemical preference for a saturated fatty acid in the sn-1 position and an 
unsaturated fatty acid in the sn-2 position in PLs (Stubbs and Smith, 1984).  This homeostatic 
mechanism may therefore maintain a relatively constant level of membrane fluidity despite large 
fluctuations in dietary fatty acid profile. Although it is not possible to greatly alter the ratio of 
saturated to unsaturated fatty acids in muscle PLs, it is possible to change the proportions of the 
different classes of unsaturated fatty acids. The greatest difference in PL fatty acid content 
between type I and type IIB muscle fibres was reported in the saturated fatty acids of the 
phosphatidylcholine species (Blackard et al., 1997). EDL muscle, constituting of 58% type IIB 
fibre in rat (Delp and Duan, 1996) had a much higher 16:0 and a significantly lower 18:0 
compared to soleus muscle. 18:2n-6 and 18:3n-3 fatty acids tend to be similar in the 
phosphatidylcholine fractions between these muscle types. Longer-chain n-3 fatty acids (22:5n-3 
and 22:6n-3) have been reported to be decreased in phosphatidylcholine from EDL as compared 




Figure 4. The common classes of phospholipids. a) Molecular structure of a typical phospholipid  
b) Molecular structure of a typical triglycerol moiety. R1, R2 and R3 indicate sn-1, sn-2 and sn-3 







2.1 Fatty Acid Stable Isotope Measures by Gas Chromatography Mass Spectrometry 
2.1.1 Gas chromatography (GC) 
The process of chromatography involves partition of the components of a mixture 
between two phases, a mobile phase and a stationary phase. The technique of gas-liquid 
chromatography or gas chromatography is a form of partition chromatography in which the 
mobile phase is a gas and the stationary phase is a liquid. A basic gas chromatograph has three 
essential components; an injector, the column, and a detector. Fatty acid methyl esters (FAME), 
dissolved in a non-polar solvent such as hexane, are first vaporized in the injection port at 
temperatures nearing 300ºC. A carrier gas such as hydrogen or helium then carries the gaseous 
fatty acids to the column as the mobile phase. The inside of the column is coated with a liquid 
compound that is the stationary phase. In order to speed the movement of the gaseous fatty acids 
through the column, it is necessary to raise the column oven temperature in a systematic fashion 
up to temperatures nearing 250ºC. As the gaseous fatty acids move through the column, they 
interact with the stationary phase. Factors relating to the chemical makeup of the stationary 
phase, for example its polarity, as well as the molecular weight and structure of the fatty acids 
determine the delay between the injection of the sample and each fatty acids column exit, also 
termed “retention time” (Christie, 1989). The longest chain and most unsaturated fatty acids have 
the longest retention times. Separations using conventional GC techniques typically lasted up to 
120 minutes. Advances in GC techniques have allowed this time to be reduced to as low as 8 
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minutes (Masood, Stark, and Salem, Jr., 2005).  Upon exiting the column, the sample is analyzed 
by a detector.  For fatty acids, a flame ionization detector (FID) is commonly used, which uses a 
hydrogen flame to combust the hydrocarbon chain.  This combustion produces ions, which 
contact an electrode, resulting in a measurable electronic current that is converted into a response 
curve or “peak” for each fatty acid.  The area under the curve for each peak can be integrated to 
quantify the fatty acids.  The advantages of the FID include simple design, low cost and low 
maintenance, high sensitivity, and linear responses (Christie, 1989).  A standalone GC can be 
used to analyze individual fatty acids from a total lipid extract.  The GC can also be coupled to a 
MS with the MS serving as the detector.  
2.1.2 Mass Spectrometry (MS)  
The key components of a mass spectrometer are the ion source, the mass analyzer and the 
detector. The principle of the technique in its simplest form is that organic molecules in a vapour 
phase are bombarded with electrons and form positively charged ions. These ions are analyzed 
by the means of mass analyzer based on their mass to charge ratio (m/z). Subsequently they are 
collected and detected in sequence as the ratio increases with an amplified signal of each (m/z) 
ratio recorded and visualized by a computer. Of the many different ionization techniques in use 
today, electron ionization (EI) and chemical ionization (CI) are the most common in the field of 
lipid research. Both have unique advantages and certain key limitations (Table 2). 
In EI, electrons are first produced by heating and passing a current through a thin 
filament. The collision of electrons with the sample molecules (M), leads to their ionization by 
electron loss with the formation of the molecular ion M
+●
. CI is related to the EI method except 
that ionization of a reagent gas (e.g. methane or isobutane), rather than the sample molecule 
itself, occurs first. This is followed by the transfer of charge to the sample molecule by a 
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chemical process. The indirect ionization via a CI method is a much softer ionization technique 
relative to EI and can greatly reduce fragmentation of the sample analyte, resulting in a higher 
proportion of unfragmented analyte or “parent ion”. Many different reagent systems have been 
used to significantly improve sensitivity and resolution of CI-MS. The choice of reagent system 
depends on analytical requirements such as sensitivity, resolution, and linear quantitation 
(Barker, 2000). Chemical ionization reagents include methane, hydrogen gas, isobutane, 
methanol, and ammonia. Two CI methods have been developed; positive chemical ionization and 
negative chemical ionization.  
Table 2. Advantages & disadvantages of EI vs. CI 
  EI   CI 
  Hard Ionization   Soft Ionization 
Cons High levels of fragmentation Pros Low levels of fragmentation 
  Low level of parent ion   High levels of parent ion 
  Low quantitative values    High quantitative values 
  Single method of ionization   Multiple choice of reagent ions 
  Consistent spectra    Incongruent spectra  
      
Pros EI mass spectra library  Cons No CI mass spectra library 
  High qualitative values   Moderate qualitative values 
  Low maintenance    High maintenance 
 
2.1.3 Positive chemical ionization (PCI) 
Chemical ionization using positively charged reagent ions is termed positive chemical 
ionization. Lower sample fragmentation and higher selectivity in sample ionization contribute to 
the higher sensitivity and resolution of PCI as compared with EI. The low internal energy 
associated with the PCI protonation process results in a much lower excitation state for the 
ionized sample molecule.  As a result, fragmentation in PCI is lower than EI (Harrison, 1992).  
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The efficiency of the protonation process depends in part on the sample’s proton affinity and the 
reagent’s acidity, both of which can be manipulated. Thus it is possible, through certain sample 
preparation techniques, to increase the proton affinity of a desired set of compounds in complex 
mixture so as to ensure that only those particular compounds are ionized by reagent ions 
(Harrison, 1992). 
Fragmentation in PCI takes place through several complex processes that lead to the 
formation of certain distinct types of fragments. These fragments can be monitored to enhance 
the sensitivity of detection and accuracy of quantification. The most common of these 
fragmenting processes include small mass fragmentation, high mass fragmentation, hydride 
abstraction, and adduct formation (Berberich et al., 1989). 
2.1.4 Negative chemical ionization (NCI) 
In negative CI, energetic electrons are first reacted with a reagent gas. This reaction 
causes the electrons to impart much of their energy onto the reagent molecules, and in the 
process become low energy or “thermal” electrons. These thermal electrons can then readily 
attach to molecules with high electron affinity (Harrison, 1992). This technique is also known as 
“electron-capture” chemical ionization. Since this electron capture occurs with very little internal 
energy, there is even less fragmentation of the sample molecule as compared with PCI (Harrison, 
1992).  As well, sample preparation techniques allow for the ionization of very select groups of 
compounds, significantly reducing background ionization. These two factors give NCI higher 
sensitivity and resolution as compared with PCI (Harrison, 1992). Limits of detection for fatty 
acids have been reported at as low as 20fg/uL (Goto et al., 1987), and responses more than 2000 
times higher than PCI (Pawlosky, Sprecher, and Salem, Jr., 1992). Less fragmentation also 
means more available sample, and therefore lower sample concentration requirements (Harrison, 
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1992). However, NCI is not without its limitations. These include complex and time-consuming 
sample preparation techniques, and high equipment maintenance demands. Fatty acid analysis 
with NCI requires preparation of pentafluorobenzyl (PFB) esters. The PFB group enables the 
fatty acid to be more electrophilic so as to better attract thermalized electrons. The entire PFB 
derivitization process requires more steps than methyl ester formation that is done in PCI. It also 
requires larger volumes of solvents such as hexane, and longer dry times under N2. The electron 
capture process also requires the availability of a larger volume of thermal electrons. As a result, 
the filament emission current in NCI is more than 15 times higher than that of PCI. This results 
in shorter filament operating times which is not trivial as filament assemblies are expensive, and 
instrument shutdown results in significant post start-up diagnostics and tuning. 
2.1.5 Mass-selection 
 Mass-selection allows for the selection of a single reagent ion, based on its mass, and 
then allows only that selected reagent ion to ionize the sample. Using this technique, the reagent 
ion with the lowest energy can be used thereby minimizing the fragmentation of the parent 
compound. Mass-selection techniques have been demonstrated in environmental contaminant 
assessments for PCBs (Lausevic et al., 1995), and alkylbenzenes (Berberich et al., 1989) but not 
for fatty acid analysis. Mass-selection was used in the development of the novel internal 
isobutane technique for this thesis. Detailed scanning procedures for mass-selection are provided 
in Methods under “Mass selection”.  
2.1.6 Selected ion monitoring 
Selected ion monitoring (SIM) generates peaks that correspond to the abundance of one 
or more user-defined ion masses. This tool was used in all isotopic quantification work in this 
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thesis. Fatty acid stable isotopes labelled with 
13
C co-elute chromatographically with endogenous 
unlabelled fatty acids. As a result, the total ion chromatographic peak cannot be integrated to 
quantify the isotope. The first step is to select for the most abundant ion of a FAME, by its mass 
to charge (m/z) value. In PCI however, any given FAME generally produces more than one high 
mass fragment ions. Table 3 below lists some of the common ion m/z values that are used in 
SIM to quantify the respective isotopic FAMEs. When more than one m/z is used in SIM, the 
response is amplified, the shape of the chromatographic peak is clearer, and is thus simpler to 
quantify. 
Table 3. Mass to charge (m/z) values of select isotopic FAMEs, ionized using isobutane PCI.  
Isotopic FAME Monitored m/z values 
13
C18-18:2n-6 313, 311, 281 
13
C18-20:3n-6 339, 337, 307 
13
C18-20:4n-6 337, 335, 305 
  
2
H5-18:2n-6 284, 282, 252 
2
H5-20:3n-6 310, 308, 278 
2

























Bolded numbers are parent ion m/z values; the rest are other high-mass fragment ions. FAME, 
fatty acid methyl esters; PCI, positive chemical ionization; m/z, mass to charge ratio. 
2.1.7 Feasibility of present MS techniques 
Presently, GC-MS techniques used for fatty acid stable isotope analyses include 
transmission quadrupole, isotope ratio mass spectrometry (IRMS), and quadrupole ion trap.  
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Each type of GC-MS technique has unique properties particularly in regards to the ionization of 
the analyte and separation of the ions before detection. 
Transmission quadrupole mass spectrometer consists of four precisely straight and 
parallel rods arranged that the beam of ions from the ionization source of the spectrometer is 
directed axially between them. Direct current and radio frequency currents are applied between 
adjacent rods, opposite rods being electrically connected. As these voltages are increased, ions 
with increasing instability are ejected from the tunnel and propelled toward the detector (Barker, 
2000). The resolution of the spectrometer can be increased by either employing eight poles or by 
connecting two or three quadrupoles in series. 
In IRMS, samples are generally combusted or pyrolyzed completely and the desired 
elemental species is then detected. For an isotopic sample containing 
13
C, the compound is 
combusted to CO2 gas, ionized and propelled to the detector. The process is element-specific and 
therefore must be changed to allow analysis of isotopic N, O, S, etc. (Godin, Fay, and 
Hopfgartner, 2007). This allows for greater sensitivity and accuracy in determining specific 
isotope ratios. However, it is critical that analytes are completely separated before entering the 
mass spectrometer, so only one compound at a time is analyzed. IRMS requires cleaner and 
higher sample concentrations, is more expensive, and requires dedicated and highly trained 
technical personnel (Godin, Fay, and Hopfgartner, 2007).  
An ion trap assembly consists of three electrodes; a ring electrode, an entrance electrode, 
and an exit electrode that are separated by quartz spacers and contained in a heated oven. These 
electrodes have hyperbolic inner surfaces that together form a cavity in which ionization, 
fragmentation, storage, and mass analysis take place. This allows ionization to take place at low 
pressures, and with extremely low sample concentrations. It is also possible to selectively eject 
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desired ions to the detector which enables MS
n
 analyses. These factors combined with the very 
short distance between the trap and the detector allow for very high sensitivity and resolution 
compared to transmission quadrupole analyzers where ions flow continuously from the 
ionization source to the detector (Barker, 2000; Downward, 2004). The ion trap MS is also fairly 
resilient instrument that is less technically demanding than an IRMS.   
The Varian 4000 quadrupole ion trap GC-MS is capable of operating in three distinct 
ionization configurations; internal, external and hybrid.  When the system is in internal 
configuration, analytes eluting from GC column directly enter the trap and ions are generated in 
the ion trap via electrodes that resides just outside the trap’s entrance electrode. In external 
configuration, after the sample is ionized outside the trap in an external source, three lenses are 
used to direct the resulting ions towards the trap using electrostatic focusing. Hybrid 
configuration is a new ionization technique for quadrupole ion trap GC-MS systems which 
combines the valuable features of external ionization and internal ionization with removal of the 
critical issues for both. In the hybrid configuration reagent ions are generated in the external 
source and then drawn into the trap and only those selected are allowed to react with analytes 
eluting from GC column directly inside trap. This approach has a number of potential advantages 
including; avoiding ion molecules reactions with the neutral reagent and avoiding losses of 
sample ions that occur when they move from external source to the trap (Varian, 2006).  
2.2 Fatty Acid Stable Isotope Tracer Study in Skeletal Muscle 
2.2.1 Study design options 
The single-labelled experimental design is the most widely used approach in tracer 
studies and involves administration of a pulse (i.e. one-time dosing) oral bolus of one labelled 
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fatty acid. A superior approach is the multiple simultaneous stable isotope design (MESSI) that 
involves administration of a pulse oral bolus of a mixture containing two or more labelled fatty 
acids (Emken, 2001). The advantage of the latter design compared to the former is that the 
metabolic fate of two or more fatty acids can be directly compared in the same subject under 
identical experimental conditions. Other advantages of the MESSI design are that a labelled fatty 
acid, such as oleic acid (18:1n-9), can be used as an internal standard and each subject can serve 
as his or her own control. As an example of the latter design, fractional synthesis rates of 
intramuscular TG in rat gastronemius and soleus muscles were evaluated using two isotopic 
labelled fatty acids (i.e. U-
13
C palmitate and 1-
13
C oleate) and it was found that the fractional 
synthesis rates of intramuscular TGs in gastrocnemius were significantly higher as compared 
with soleus for palmitate (P = 0.04) and oleate (P = 0.02) (Guo and Jensen, 1998).   
Gavage is the method of choice for the oral administration of stable isotope fatty acids 
due to the consistency in delivering an accurate dose of stable isotope into the digestive tract of 
the experimental animals. With gavage, the desired food or nutrients are generally delivered to 
the stomach by passing a feeding tube or a blunt needle through the nose or mouth into the 
esophagus. Besides its application in research, gavage has been used frequently in medicine 
particularly to feed babies who are not able to suck or swallow enough of good nutrition.  
2.2.2 Stable isotope options  
Deuterated (
2
H) and carbon 13 (
13
C) labelled fatty acids are the most widely used stable 
isotope fatty acids in human and animal studies (Burdge and Wootton, 2002; Lin and Salem, Jr., 
2007; DeMar, Jr. et al., 2008). 
13
C isotopes have a smaller mass difference and similar 
physiological properties to 
12
C, but endogenous fatty acids can suppress 
13
C signals more than 
deuterated signals in a mass spectrometer (Lin, Pawlosky, and Salem, Jr., 2005). The deuterated 
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isotopes (typically D-5 at the two terminal methyl end carbons) are useful in tracking the fate of 




C) isotopes provides the ability to 
potentially track the metabolic fate of the labelled fatty acid including oxidation to CO2 if gas 
analyzers are utilized (McCloy et al., 2004). The typical amount of tracer in a pulse-oral-dose in 
vivo experiment is 30-50 mg/kg body weight of 95% enriched deuterated labelled fatty acid as 
compared with 2-10 mg/kg body weight of a 99% enriched U-
13
C labelled fatty acids (Emken, 
2001).  
2.2.3 Issues 
Delivering a consistent dose of isotopically labelled fatty acids to all of the experimental 
animals is the major issue due to the micro scale of the dose and the viscous nature of the fatty 
acids. In addition, expression of the isotope data can be challenging. Stable isotope tracer data 
has been expressed in a variety of units (e.g. percentage enrichment, tracer/tracee ratio, weight, 
and percentage of total tracer). In addition advanced modelling is also often used.  Each 





RATIONALE & OBJECTIVES 
3.1 RATIONALE 
Previous investigations using stable isotope method have provided detailed analysis of 
PUFA uptake and metabolism by the liver, nervous system and blood (Sheaff et al., 1995), and 
some examination of other organs such as heart, lung and kidney (Su et al., 1999). Nevertheless 
the number of studies dedicated to the analysis of PUFA uptake and metabolism in skeletal 
muscle are limited and their findings are trivial with respect to the fibre type differences (DeMar, 
Jr. et al., 2008; Lin and Salem, Jr., 2007). Consistent and striking discrepancies in the PUFA 
content between different muscle types addressed in numerous compositional studies (Gorski, 
Nawrocki, and Murthy, 1998; Infante, Kirwan, and Brenna, 2001; Stark, Lim, and Salem, Jr., 
2007) imply fibre type discrimination in PUFA uptake and metabolism. Moreover, the PUFA 
requirements may differ between muscle types possibly due to fibre type-specific SERCA 
activity and mitochondrial oxidation function. To our knowledge, this study will be the first work 
to offer comprehensive results on the uptake, distribution, and incorporation of PUFA stable 
isotopes in specific muscle types (i.e. soleus, red and white gastrocnemius). The anticipated 
results from these studies would lead to a much greater understanding of the role of fatty acids, 
particularly PUFA, in skeletal muscle function and would be the first step toward understanding 




The overall objective of this thesis is to compare PUFA distribution and metabolism in 
skeletal muscle types with distinct fibre type composition; namely soleus (slow-twitch 
oxidative), red gastrocnemius (fast-twitch oxidative), and white gastrocnemius (fast-twitch 
glycolytic) up to 48 h. The first objective is to quantify the endogenous pools of fatty acids in the 
muscle types to confirm previously published results of PUFA differences between various 
muscle types (Blackard et al., 1997; Gorski, Nawrocki, and Murthy, 1998; Kriketos et al., 1995; 
Nikolaidis, Petridou, and Mougios, 2006). The second objective is to evaluate muscle uptake and 
metabolism of commercially available linoleate stable isotopes (ethyl 
13
C18 -18:2n-6, NEFA 
13
C18 -18:2n-6 and ethyl 
2
H5 -18:2n-6) in soleus, red and white gastrocnemius muscle 8 h after a 
single oral dose while validating a novel internal isobutane GC-MS ion trap technique. The third 









H2-18:1n-9 to examine PUFA distribution in contrast to saturated and 
monounsaturated fatty acid distribution in soleus, red gastrocnemius, white gastrocnemius and 
heart muscle at 8h, 24h and 48h. In addition we will examine the accumulation of longer chain 
fatty acids derived from 18:2n-6 and 18:3n-3, in particular 20:4n-6 and 22:6n-3. It is also our 
intention to extend fatty acid composition and stable isotope analyses to individual lipid class 
fractions (TG, PL and NEFA) in order to gain better insights to the main depository destination 
for each PUFA inside the muscle. 
In order to accomplish these objectives it was necessary to first develop an ion trap GC-





labelled fatty acids. Fatty acid stable isotopes are currently considered the as gold standard 
technique for examining fatty acid metabolism in tissue but GC-MS fatty acid tracer analyses in 
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the literature have predominantly used transmission quadrupole GC-MS techniques followed by 
GC combustion IRMS. Initial efforts in method development included duplicating a common 
transmission quadrupole GC-MS method (Lin and Salem, Jr., 2007) with chemical ionization 
techniques using the ion trap GC-MS in external mode, followed by the development of a novel 
positive chemical ionization method using isobutane with the GC-MS in internal mode. 
3.3 HYPOTHESIS 
 Concentration of the endogenous pools of 18:2n-6, 18:3n-3, 20:4n-6 and, 22:6n-3 will be 
significantly higher in soleus as compared to that from red and white gastrocnemius 
muscles which will exhibit similar concentrations.  
 Ethyl ester form of 13C18-18:2n-6 will be the most cost and dose effective form of 
linoleate stable isotope. 
 Preferential accumulation of the labelled 18:2n-6 and 18:3n-3 will occur in the order of 
soleus > red gastrocnemius > white gastrocnemius.   
 Significantly higher amount of n-6 and n-3 isotopic labelled metabolites will be detected 







4.1 Study Design  
After establishing a GC-MS ion trap method with the sensitivity to detect the isotopic 
fatty acids in various skeletal muscle types, two separate tracer studies were designed to achieve 
the main objectives of this thesis. In the first tracer study known as “linoleate study” male 
Sprague-Dawley rats were obtained from Harlan Laboratories (Indianapolis, IN) at the age of 3 
weeks and maintained under conventional conditions with controlled temperature (22°C) and 
illumination (12 h; 6:00 AM to 6:00 PM). After having been fed on Harlan Teklad 8640 rodent 
diet (Table 4) ad libitum with free access to water for 10 days, they were randomly assigned into 
four groups (n = 4/group), fasted overnight and administered a single oral bolus (0.15 mg/g body 







H5 18:2n-6 EE mixed in 0.48 mL of olive oil and only the vehicle oil was given to 
the control group. Animals were then returned to their cages for 8 h, where they had normal 
access to food and water. At the end of the experimental period, animals were anesthetised by an 
intraperitoneal pentobarbital sodium (30 mg/kg) injection and soleus, red gastrocnemius, and 
white gastrocnemius muscles were carefully excised with visible adipose tissue and fascias 
removed and immediately frozen in liquid nitrogen and stored at -80 °C for later analysis. Rats 
were euthanized by exsanguination followed by removal of the heart. A schematic diagram of 
the linoleate study is depicted in Figure 5A. As mentioned previously the purpose of the 
linoleate study was to evaluate muscle uptake of the available linoleic acid stable isotopes 8 h 
after oral gavage. The design for the second tracer study known as the “MESSI study” was 
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similar to the linoleate study except for the following; 1) twenty five male rats were used 









H2-18:1n-9) were given (0.15 mg/g body 
weight; ~ 20.4 mg). For example, one dose would have 20 mg of every stable isotopic fatty acid 
which adds up to 80 mg of total stable isotopic fatty acid in addition to 0.4 mL of olive oil. A 
schematic diagram of the MESSI study is depicted in Figure 5B.  
Finally in order to compare the concentration of endogenous pools of fatty acids among 
various muscle types, part of the muscle samples (i.e. soleus, red gastrocnemius, and white 
gastrocnemius muscles) from the control animals in the linoleate and MESSI study were 
subjected to the fast GC-FID analysis. 
SFA; saturated fatty acids; MUFA; mono-unsaturated fatty acids; PUFA; polyunsaturated fatty acids. 
 
Table 4. Fatty acid composition of Harlan Teklad 8640 rodent diet.  
    
Fatty Acid Relative Composition (%) Fatty Acid Relative Composition (%) 
        
14:0 0.5 18:2 n-6 46.6 
16:0 14.7 20:4 n-6 0.04 
18:0 4.6 Total n-6 PUFA 47 
Total SFA 20.1   
  18:3 n-3 5.1 
18:1 n-9 20.7 20:5 n-3 0.3 
Total MUFA 23.5 22:6 n-3 0.2 








4.2 Isotope and Chemicals 
Deuterium-labelled ethyl linoleate (
2
H5-17,17,18,18,18-18:2n-6 EE), carbon-13-
uniformly labelled ethyl linoleate (
13
C18-18:2n-6 EE), deuterium-labelled ethyl linolenate (
2
H5-
17,17,18,18,18-18:3n-3 EE), carbon-13-uniformly labelled ethyl palmitate (
13
C16-16:0) and 
deuterium-labelled nonesterified oleic acid (
2
H2-9,10-18:1n-9 NEFA) were obtained from 
Cambridge Isotope Laboratories (Andover, MA); isotope purities were > 98%, >96%, >90%, 
>95% and >98% respectively. Carbon-13-uniformly labelled nonesterified linoleate (U-13C-
18:2n-6 NEFA) was obtained from Spectra Stable Isotope Inc., (Columbia, MD); isotope purity 
was > 98%. Unlabelled commercial reference standard 462 and unlabelled fatty acids were 
purchased from Nu-Chek Prep Inc., (Elysian, MN). 
4.3 Homogenization, Lipid Extraction and Derivatization Reactions 
Muscle samples were thoroughly diced at 4°C and disrupted in 2 mL methanol containing 
0.01% butylated hydroxytoluene with a polytron homogenizer (Fisher Scientific, Hampton, NH). 
A known amount (~50ug/sample) of internal standard (17:0, 19:0 or 22:3n-3) was added to each 
sample prior to the homogenization. Total lipids were extracted from muscle homogenate (Bligh 
and Dyer, 1959) followed by direct transmethylation using 14% boron trifluoride (BF3) in 
methanol (Morrison and Smith, 1964) as modified to include hexane (Salem, Jr., Reyzer, and 
Karanian, 1996). 
4.4 GC-MS Analysis of the Stable Isotope Fatty Acids 
A Varian 4000 Ion Trap GC-MS system (Varian Canada Inc., Mississauga, ON) was used 
for the quantification of fatty acid stable isotopes. An aliquot of 1 µL of FAMEs per sample was 
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injected using a Combipal autoinjector (CTC Analytics AG, Switzerland, Zwingen) onto a DB-
FFAP 60m x 0.25mm i.d. x 25um film thickness, capillary column (J&W Scientific from Agilent 
Technologies, Mississauga, ON). The column was interfaced directly into positive chemical 
ionization (PCI) system using isobutane as the reagent gas with helium as the carrier gas. The 
GC oven temperature was programmed from 50°C to 130°C at the rate of 30°C/min followed by 
an 8°C/min ramp to 175°C, a 1°C/min ramp to 210°C, and a 30°C/min ramp to 245°C with a 30 
min hold at the end. The injector and transfer line temperatures were maintained at 260°C and 
250°C, respectively. Source temperature and manifold temperatures were 180°C and 50°C, 
respectively. Selected ion monitoring was carried out both for precursors and the main 
metabolites, using ions presented in Table 3. To reduce fragmentation and increase the level of 
control over sample ionization by chemical ionization, the instrumental parameters were set to 
allow mass-selected ion/molecule reaction to occur. With isobutane as the reagent gas, several 









 respectively. However, only [C4H9]
+
 ions which chiefly result in proton 
transfer (i.e. [MH]
+
 ion) were allowed to react with the sample molecules.  
4.5 Fast GC Analysis  
To quantify the endogenous pools of fatty acid in various muscle types fast GC-FID 
analysis (Masood and Salem, Jr., 2008; Masood, Stark, and Salem, Jr., 2005) was performed on a 
Varian 3900 system using a DB-FFAP of 15m × 0.1 mm ID × 0.1 µm film thickness (J&W 
Scientific from Agilent Technologies, Mississauga, ON).  For the fast GC analysis, the 
temperature program included an initial temperature of 150°C with a 0.25 min hold followed by 
a 35°C/min ramp to 200°C, a 8°C/min ramp to 225 with 3.2 min hold, and then 80°C/min ramp 
to 245°C with 2.75 min hold. Carrier gas was H2 at a flow rate of 0.5 ml/min with constant head 
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pressure of 344.7 kPa, and a split ratio of 100:1.  The FID was set at 250°C with air and nitrogen 
make-up gas flow rates of 300 ml/min and 25ml/min, and a sampling frequency of 80 Hz.  The 
Combipal autosampler (CTC Analytics AG, Switzerland, Zwingen) was set to inject 1 µL 
volume. Total run time for a single sample was 23.25 min.  
4.6 Thin Layer Chromatography (TLC) Analysis  
The lipid classes were fractionated by TLC on plates (20 × 20 cm) coated with silica gel 
60 A and thickness of 250 µm (Whatman International Ltd. Maidstone, UK) using heptane: ethyl 
ether: acetic acid (60:40:3, v/v/v) (Christie, 2003) as the developing solvent. TLC standards for 
the TG fraction (triheptadecanoin; Nu-Chek Prep Inc., Elysian, MN) and PL fraction (1,2-
dihetadecanoyl-sn-glycero-3-phosphocholine; Avanti Polar Lipids Inc., Alabaster, AL) were 
added to one aliquot (300 µl) of the total lipid extract and the mixture was dried under nitrogen 
stream. Dried lipids were dissolved in 50 µl of chloroform prior to applying to the TLC plates. 
Following this procedure, the plates were placed in the developing solvent for approximately 
45min. The plates were allowed to dry at room temperature and lipid bands were visualized 
under UV light after spraying with a 0.5% solution of dichlorofluorescein prepared in ethanol. 
The gel band corresponding to PL, TG and NEFA were scraped off the plate and transferred into 
screw cap glass tubes. Fatty acids were then transmethylated in the presence of 14% BF3 in 
methanol (v/v) at 100°C for 1 h. The resulting methyl esters were extracted and analyzed by GC-
MS to measure the isotopic signal present in different lipid fractions.  
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4.7 Standard Curves 
4.7.1 Standard curves for isotopic precursor.  
For each isotopic precursor stock solution, a series of serial dilution were made and a 
constant amount of internal standard (ISTD) 17:0 ethyl ester was added. The range of these 
samples covered the estimated range of isotope-labelled fatty acid in rat muscle samples. 
Standard curves were determined using linear regression of the ratio of signal areas between 
isotopes and ISTD versus the ratio of amounts between isotopes and ISTD  
4.7.2 Standard curves for isotopic metabolites. 
 To estimate the slopes of the standard curves for the major isotopic metabolites for which 
stable isotope-labelled compounds were not available, the ratios of the slopes determined from 





H5-18:2n-6) were used as previously described (Lin, Pawlosky, and Salem, Jr., 2005). For 
example, to determine the standard curve for 
13
C18-20:4n-6, it was assumed that the relationship 
of the slopes of unlabelled 18:2n-6 and 
13
C18-18:2n-6 was the same as that of unlabelled 20:4n-6 
and 
13
C18-20:4n-6. The intercepts were generally very close to the origin and so are not specified. 
4.7.3 Standard curves for the unlabelled fatty acids. 
 Stock solution of each unlabelled fatty acid were diluted into a series of working 
solutions with a range of 5-100 ng per sample with ISTD added to each sample. Both the 
isotope-labelled and unlabelled samples were processed similarly for GC-MS analysis.  
38 
 
4.8 Statistical Analysis 
Statistical analyses were performed using GraphPad Prism (Version 4, GraphPad 
Software Inc., San Diego, CA) and SPSS (Version 16.0, SPSS Inc., Chicago, IL). All values are 
expressed as means ± SEM. To compare the differences in endogenous pools of fatty acids 
among various muscle types one-way ANOVA was conducted with Tukey’s honestly 
significantly difference test as the post hoc test. The potential for significance was inferred at P < 
0.05. All statistical analyses associated with both linoleate and MESSI study were two-way 
ANOVA in conjunction with the appropriate post hoc test to determine the significant 
differences between the individual means. In the linoleate study, 18:2n-6 isotope and tissue 
effects were examined, and in the MESSI study, tissue and time effects were examined.  
Significance was inferred at P < 0.05. A least-squares linear fitting procedure was used to 
determine the standard curves of isotopic and unlabelled fatty acids. When the regression 






5.1 Comparison of Endogenous Pools of Fatty Acids in Various Muscle Types  
Fatty acid composition of total lipid extracts from soleus, red gastrocnemius, white 
gastrocnemius and heart were expressed in concentrations (Table 5) and relative mole 
percentages (Table 6).  Total fatty acid concentrations were significantly higher (~ 2-fold) in 
soleus as compared with red and white gastrocnemius which exhibited similar concentrations. 
These differences were mainly a result of much higher concentration of total monounsaturates 
(over 3-fold), but total saturates, total PUFA and total n-6 PUFA concentrations in soleus were 
also significantly higher. Nonetheless, concentrations of HUFA in soleus did not differ from red 
and white gastrocnemius. Concentrations of fatty acids in heart were similar to that of soleus, 
except for a significantly higher HUFA and total n-3 PUFA. When fatty acids were expressed as 
relative mole percentages, the fatty acid composition of soleus tended to resemble white 
gastrocnemius in total PUFA, total n-6 PUFA and total n-3 PUFA, however the proportions of 
total saturates and total HUFA were significantly lower in soleus compared to white 
gastrocnemius. In contrast, proportions of total monounsaturates in soleus were significantly 
higher than white gastrocnemius. As compared to red gastrocnemius, soleus had significantly 
lower percentages of total PUFA and subclasses of PUFA including total n-3 PUFA and total 
HUFA. In regard to total saturates and total monounsaturates, red gastrocnemius composition 
was similar to white gastrocnemius as compared to soleus. Interestingly, proportions of fatty 
acids in heart muscle are in close agreement with that of red gastrocnemius.  
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The fatty acid composition also varied at the level of the individual fatty acids. Most 
importantly, both concentrations and proportions of 18:2n-6 and 18:3n-3 were significantly 
higher in soleus as compared with red and white gastrocnemius muscle which exhibited similar 
values. Heart content of 18:2n-6 and 18:3n-3 were similar to those of red and white 
gastrocnemius muscles. Although soleus and gastrocnemius muscles showed similar 
concentration of 20:4n-6, the proportions of this fatty acid were significantly higher in red and 
white gastrocnemius relative to soleus. Heart concentrations of 20:4n-6 along with its 
proportions were significantly higher (~ 2 fold in concentration and 1.5 fold in mole percentage) 
relative to the skeletal muscles. In regard to 22:6n-3, soleus resembled red gastrocnemius in 
concentrations which were significantly higher than white gastrocnemius 22:6n-3 concentrations. 
In term of relative mole percentages of 22:6n-3, soleus had similar percentages as white 
gastrocnemius and both showed higher proportions compared to red gastrocnemius. While heart 
concentration of 22:6n-3 was higher than all skeletal muscles, there were no differences as 
compared with red gastrocnemius when DHA was expressed as relative mole percentage. 
5.2 Linoleate Study 
5.2.1 Fibre type-specific uptake of deuterium-and carbon-13-labelled linoleate 
The accretion of the linoleate tracer in specific muscle types is expressed as net 
accumulation (nmol/g of muscle, Figure 6A) and percent enrichment (concentration of labelled 
linoleate/concentration of endogenous pool of linoleate, Figure 6B). The net accumulation of 
NEFA and EE forms of 
13
C labelled linoleate among various muscle types were in the order of 
soleus > red gastrocnemius = white gastrocnemius (P < 0.05). Similar rank order was observed 
for that of 
2
H labelled linoleate (EE only) however, the differences between the muscle types did 
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not reach significance. There was a good agreement between the net accumulation data with that 
of percent enrichment (Figure 6A and 6B), which further postulates the muscle type discrepancy 
in linoleate uptake and metabolism. Complementary to these results, the total amount of labelled 
linoleate in each muscle type was also expressed as the percentage of total precursor dose (Table 
7). The greatest percentage of the total precursor dose was observed in red gastrocnemius as 
NEFA 
13
C labelled linoleate (0.028 %) while 
2
H -labelled linoleate in both soleus and white 
gastrocnemius muscle was the lowest (0.002 %). The results from EE form of 
13
C labelled 
linoleate were in agreement with that of NEFA. 
5.2.2 Fibre type-specific distribution of deuterium and carbon-13-labelled linoleate derived 
metabolites in vivo 8 h post dosing  
Similar to the labelled precursor, the results from the distribution of deuterium and 
carbon-13-labelled linoleate derived metabolites in vivo 8 h after dosing were expressed in two 
units; nmol/g of muscle, and the percentage of the endogenous pool (Table 8). The principle n-6 









H5-20:4n-6). Soleus had significantly higher concentration of 
13
C18-
20:3n-6 relative to the gastrocnemius muscles (P < 0.05). Consistently, 
13
C18-20:4n-6 was solely 
detected in soleus and its concentration was in a close range with that of 
13
C18-20:3n-6. It is 
important to note that the levels of labelled metabolites in white gastrocnemius were 
undetectable. Expressing the labelled metabolites data as the percentages of total precursor dose 
was not informative since the percentages were found to be very negligible and similar among 
various muscle types. 
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5.2.3 Efficacy of deuterium and carbon-13 isotopes in tracing labelled linoleate in specific 
muscle types 8 h after single oral dose. 
13
C18-18:2n-6 (EE or NEFA) and 
2
H5-18:2n-6 are 18 and 5 atomic mass unit (amu) higher 
than the mass of unlabelled 18:2n-6 (295 amu) respectively. Likewise, metabolic products of 
these isotopic fatty acids carry the same mass differences as their corresponding tracer. 
Consistently higher amounts of 
13
C labelled precursor molecule was detected in all muscle types 
relative to that labelled with 
2
H, however this difference only reached significance when the 
NEFA form of 
13
C18-18:2n-6 was compared with 
2
H5-18:2n-6 EE (Figure 6A&B). In agreement 
with the later finding, no isotopic metabolites were detected for the 
2
H-labelled precursor in any 
of the muscle types examined (Table 8). It is noteworthy that there were no significant 
differences between NEFA and EE forms in distribution, desaturation and chain-elongation 
across muscle types. 
5.3 MESSI Study 
5.3.1 Time-course of 
13
C18-18:2n-6 and its major metabolites in various muscles  
The appearance and disappearance of 
13
C18-18:2n-6 and its major in vivo metabolites 
among various muscle types after a single oral dose are presented in Figures 7-9. The n-6 
precursor was at its maximal concentration (Cmax in nmol/g) at the first experimental time point 
of 8 h in soleus (95), heart (35), red gastrocnemius (22) and white gastrocnemius (18) and 
decreased sharply in heart and red gastrocnemius, while in soleus and white gastrocnemius it 
decayed slowly over the course of the study (See Figure 7). It is noteworthy that the net 
concentration of 
13
C18-18:2n-6 in soleus was significantly greater than that in other muscle types. 
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C18-20:3n-6 was present in all muscle tissues at 8 h and it 
gradually accumulated in all muscle types throughout the experimental period except for white 
gastrocnemius in which the 
13
C18-20:3n-6 accretion (0.2 nmol/g) was halted at 24 h and it began 
to decline slowly thereafter (Figure 8). Therefore, the 
13
C18-20:3n-6 Cmax values for soleus (1.8 
nmol/g), heart (0.7 nmol/g) and red gastrocnemius (0.3 nmol/g) were all achieved at 48 h with 
soleus net concentration of 
13
C18-20:3n-6 being significantly higher than that of other muscle 
groups. 
13
C18-20:4n-6 was detected in soleus at 8, 24 and 48 h (Cmax = 8.0 nmol/g at 48h) but was 
detected in red gastrocnemius at 8 h only (Cmax = 3.5 nmol/g), in heart at 48 h only (Cmax = 8.0 
nmol/g) and was not detected in white gastrocnemius at any time point (Figure 9).  
5.3.2 Time-course of 
2
H5-18:3n-3 and its major metabolites in various muscles 
The appearance and disappearance of 
2
H5-18:3n-3 and its major in vivo metabolites 
among various muscle types after a single oral dose are presented in Figure 10-12. Similar to the 
n-6 precursor, 
2
H5-18:3n-3 was also at its maximal concentration at 8 h in heart (20 nmol/g), red 
gastrocnemius (15 nmol/g) and white gastrocnemius (7 nmol/g), and decreased sharply by 24 h, 
particularly in heart and red gastrocnemius and remained low at 48 h in all tissues (Figure 10). 
2
H5-18:3n-3 rapidly accumulated in soleus by 8 h however, unlike the other muscle groups, 
2
H5-
18:3n-3 continued to increase and reached its Cmax (23 nmol/g) at 24 h and remained relatively 
high at 48 h. Therefore at 24 and 48 h, soleus had significantly higher concentrations of 
2
H5-
18:3n-3 than the other muscle tissues which exhibited concentrations similar to each other. 
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H5-22:6n-3 followed a different pattern. 
2
H5-
20:5n-3 was not detected in soleus at any time point, while it was detected in all remaining 
muscles at 8 h (Figure 11). 
2
H5-20:5n-3 was maximal in white gastrocnemius at 8 h (0.5 nmol/g) 
with a subsequent decline at 24 h and no detectable 
2
H5-20:5n-3 at 48 h. In red gastrocnemius 
2
H5-20:5n-3 was similar at 8 h and 24 h with a subsequent decline by 48 h. Unlike the skeletal 
muscles, heart continued to accumulate 
2
H5-20:5n-3 throughout the 48 h period. The observed 
concentrations for 
2





reached a maximal accumulation in the soleus at 8 h followed by a rapid disappearance by 24 h 
that persisted to 48 h (Figure 12). In heart and red gastrocnemius, the concentrations of 
2
H5-
22:6n-3 tended to increase over the 48 h, while 
2
H5-22:6n-3 was not detected in white 
gastrocnemius. 








H2-18:1n-9 1 were included in our study to compare the sensitivity of our 
analytical method with previous studies and to examine differences between the polyunsaturates 
as compared with saturates and monounsaturates. 




H2-18:1n-9 were detected by 
8 h after dosing with 
2
H2-18:1n-9 reaching maximal concentration in all muscles at 8h (Figure 
13) and 
13
C16-16:0 in soleus, red gastrocnemius and white gastrocnemius reached maximal 
concentrations at 24 h although the concentrations at 8 h were 90-95 % of these maximums 
(Figure 14). In heart, the maximal concentration of 
13
C16-16:0 was reached at 8 h. Skeletal 
muscles maintained a high level of 
13
C16-16:0 throughout the 48 period while in heart muscle it 
reached a plateau after a sharp decrease at 24 h. In contrast, 
2
H2-18:1n-9 was completely 
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eliminated from red gastrocnemius and heart muscle after 8 h, while in the soleus and white 
gastrocnemius it was maintained at a relatively consistent level.  
5.3.4 Compartmentalization of labelled fatty acids among various lipid classes 
Due to the analyzing capacity of the GC-MS system in detecting tracer molecules, only 
precursor fatty acids which exhibited the most abundance of isotopic signal at the 8 h time point 









H2-18:1n-9 among PL, TG and NEFA fractions are plotted in Figure 
15. Most of the 
13
C18-18:2n-6 signal was found among TG fraction accounting for 50-65% of the 
signal in red and white gastrocnemius muscle (20-35% in PL fraction) and ~ 80% of that in 
soleus (~ 10% in PL fraction). A small quantity of 
13
C18-18:2n-6 (~ 1-10 %) was also detected in 
NEFA fraction. Similar to the n-6 precursor, TG fractions were the main repository compartment 
for 
2
H5-18:3n-3 however they accommodated ~ 80% of signal in red and white gastrocnemius as 





various lipid classes in heart muscle showed similar pattern as red and white gastrocnemius 
muscles.  
13
C16-16:0 showed a muscle type specific distribution pattern. In red gastrocnemius 
13
C16-
16:0 was equally distributed among various lipid classes. In white gastrocnemius, the PL fraction 
became the main repository compartment (> 60%) with TG and NEFA fractions sharing the 
remnant 
13
C16-16:0 signal equally. In the soleus, the 
13
C16-16:0 signal was mainly incorporated 
into TG, followed by PL with little signal in NEFA, a distribution similar to that of 
13
C18-18:2n-6 
in soleus. In heart muscle, TG, PL and NEFA each accumulated 45, 30, and 25 % of the total 
13





H2-18:1n-9 in red gastrocnemius and heart, > 50% of the 
2
H2-18:1n-9 was accreted 
in the NEFA fraction, ~ 25-40% in the TG fraction and a small quantity was detected in the PL 
fraction. In the soleus and white gastrocnemius, the TG fraction was the principle depot as it 
accumulated 75 to 90% of the 
2







6.1 Comments on hypotheses  
1. Concentration of the endogenous pools of 18:2n-6, 18:3n-3, 20:4n-6 and 22:6n-3 will be 
significantly higher in soleus as compared to that from red and white gastrocnemius muscles 
which will exhibit similar behaviour. 
A systematic comparison of fatty acid compositions in soleus, red gastrocnemius and 
white gastrocnemius revealed significantly higher concentrations of 18:2n-6 and 18:3n-3 in 
soleus relative to that from red and white gastrocnemius which were similar. Although the 
concentration of the endogenous pools of 20:4n-6 and 22:6n-3 were higher in soleus as compared 
with red and white gastrocnemius muscles, the difference did not reach significance. The 
concentration of total fatty acids was significantly higher in soleus as compared with red and 
white gastrocnemius which exhibited similar concentrations. These differences were a result of 
much higher concentrations of total monounsaturates (over 3-fold), total saturates, total PUFA 
and total n-6 PUFA concentrations in soleus.  
2. Ethyl ester form of 13C18-18:2n-6 will be the most cost and dose effective form of linoleate 
stable isotope. 
Results from linoleate study conclusively demonstrated that uniformly labelled carbon-13 
isotopes are the most effective form of stable isotopes to be employed in fatty acid tracer studies 
in small muscle samples as compared to those labelled with deuterium. With regard to the ester 
bonds, NEFA form of labelled fatty acids resulted in slightly higher isotopic signal as compared 
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to that of EE. However, since the difference was not found significant it was decided to carry on 
with the EE form to match with the large body of tracer studies which use EE form (Lin, 
Pawlosky, and Salem, Jr., 2005; Lin and Salem, Jr., 2007; Lin and Salem, Jr., 2005).  
3. Preferential accumulation of the labelled 18:2n-6 and 18:3n-3 will occur in the order of 
soleus > red gastrocnemius > white gastrocnemius. 
According to the results collected in our tracer studies, soleus was unequivocally the 
predominant muscle type in accumulating 18:2n-6 and 18:3n-3 followed by red gastrocnemius 
and white gastrocnemius. However, despite a slight elevation in the concentration of the labelled 
n-6 and n-3 precursors in red gastrocnemius compared to white gastrocnemius, the behaviour of 
the two portions of gastrocnemius muscle was not found significantly different from one another. 
The results from deuterium labelled isotopes also agree with the above findings. 
4. Significantly higher amounts of n-6 and n-3 isotopic labelled metabolites will be detected in 
soleus relative to that of red and white gastrocnemius which will exhibit similar behaviour  
Significantly higher concentrations of n-6 stable isotopic metabolites (20:3n-6 and 20:4n-
6) were detected in the soleus relative to red and white portion of gastrocnemius muscle, as 
confirmed with both the linoleate and MESSI study. The behaviour of the red and white 
gastrocnemius muscle in accumulating isotopic n-6 metabolites was elusive relative to one 
another and across the two studies. However, this matter is discussed later in more detail. With 
regard to the n-3 metabolites which were examined only in MESSI study, labelled 20:5n-3 was 
undetectable in soleus throughout the 48 h period while in red and white gastrocnemius muscles 
relatively high amounts of 20:5n-3 at 8 and 24 h were detected. For the 22:6n-3, soleus accreted 
a higher amount of this labelled n-3 metabolite at 8 h after dosing as compared with red 
49 
 
gastrocnemius. At 24 and 48 h, labelled 22:6n-3 was not detected in soleus, while labelled 22:6n-
3 increased in red gastrocnemius. Labelled 22:6n-3 was not detected in white gastrocnemius 
throughout the study.  
6.2 Effect of Fibre Type Composition on PUFAs Distribution in Various Muscle Types  
To our knowledge, no previous study has attempted to systematically follow PUFAs 
distribution among various muscle types with discrete fibre type composition. In two separate 
tracer studies conducted in our laboratory, it was established that PUFAs distribution varies 
among different muscle types ultimately due to their distinct fibre type composition. We 
analyzed soleus, red and white gastrocnemius muscles which have been examined in numerous 
studies as the muscle groups with distinct fibre type composition (Blackard et al., 1997; Gorski, 
Nawrocki, and Murthy, 1998; Kriketos et al., 1995; Nikolaidis, Petridou, and Mougios, 2006). 
The main reason behind the inclusion of heart muscle in some of the analyses was to provide a 
measure for a direct comparison between the efficiency of our mode of administration and 
analytical system with that published in Salem laboratory (Lin and Salem, Jr., 2007).  
6.2.1 Fibre type-specific distribution of n-6 and n-3 precursors 
Concentration (nmol/g of tissue) results from both deuterium and carbon-13-labelled 
linoleate consistently revealed that soleus was the predominant muscle type in accumulating 
significantly higher concentration of labelled linoleate as compared with red and white 
gastrocnemius which were similar. Rendering the concentration results to percent enrichments 
(i.e. concentration of labelled 18:2n-6 / concentration of endogenous pool of 18:2n-6) also 
brought about the same rank order; soleus > red gastrocnemius = white gastrocnemius. 
2
H518:3n-
3 distribution similarly resulted in higher accumulation of this tracer in soleus as compared with 
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red and white gastrocnemius. In most part, heart muscle closely resembled gastrocnemius 
muscles in accretion of n-6 and n-3 precursors. The concentration results from the heart muscle 
were in close agreement with those reported previously (Lin and Salem, Jr., 2007). Differences 
in blood flow to each muscle type at rest, discrepancy in FAT/CD 36 expression levels and 
disparity in LPL activity, all induced by fibre type compositions, are three possible explanations 
for this trend of labelled n-6 and n-3 precursor uptake among various muscle types. It has been 
shown that when the rats are standing, blood flow is highest in muscles containing large 
proportions of type I fibres (e.g. soleus muscle; 86% type I, (Delp and Duan, 1996). It was also 
suggested that type I fibres and to a lesser extent type IIA fibres (e.g. red gastrocnemius; 55% 
type I and 31% type IIA, (Delp and Duan, 1996) are the primary types of fibres recruited during 
postural maintenance. As the rats begin to walk at 15 m/min, there is a close relationship 
between the increase in blood flow above rest and population of recipient type IIA fibres in 
muscles. Type IIB fibres (e.g. white gastrocnemius; 95% type IIB (Delp and Duan, 1996) had a 
negligible blood supply until the rats were running at the moderate intensity of 60 m/min 
(Armstrong and Laughlin, 1985; Delp et al., 1991; Laughlin and Armstrong, 1983). Since the 
rats in our study were kept in small cages throughout the study one can speculate that soleus 
uptake of labelled linoleate and linolenate may be partially due to its markedly higher blood 
supply as compared with red and white gastrocnemius muscles (Delp et al., 1991). A high level 
of fat transporters (i.e. FAT/CD 36) in the soleus plasma membrane, and high LPL activity in 
soleus capillary beds also supports a high uptake of labelled fatty acids by the soleus. LPL 
activity and FAT/CD 36 expression have been shown to be fibre type specific with being highest 
in red muscle and lowest in white muscle (Bonen et al., 1998; Smol et al., 2001).  
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The marked difference in 18:2n-6 and 18:3n-3 uptake and incorporation between soleus 
and gastrocnemius muscles appears to be associated with the endogenous pool of these fatty 
acids within these specific tissues. In the present study 18:2n-6 and 18:3n-3 content of soleus 
were found 2-fold and 5-fold, respectively, greater than red and white gastrocnemius which had 
similar concentrations that agrees with previous reports (Blackard et al., 1997; Gorski, Nawrocki, 
and Murthy, 1998; Kriketos et al., 1995; Nikolaidis, Petridou, and Mougios, 2006). Therefore, 
the high concentration of labelled n-6 and n-3 precursors in soleus is likely due to specific 
requirements and/or larger endogenous pools (TG and PL) for these fatty acids. This may be a 
result of different rates of uptake, retention or partitioning away from β-oxidation in the soleus as 
compared with other muscles.  With regard to behaviour of the heart muscle, it is important to 
mention that the endogenous concentrations of 18:2n-6 and 18:3n-3 in this tissue were near those 
found in red and white gastrocnemius muscle. However further elaboration on the heart uptake 
of labelled n-6 and n-3 precursors compared to the skeletal muscle is beyond the scope of this 
document.   
6.2.2 Fibre type-specific distribution of n-6 and n-3 metabolites 
As it was expected from the labelled 18:2n-6 results, soleus was labelled with 
significantly higher concentrations of the principle n-6 metabolites (20:3n-6 and 20:4n-6) 
relative to red and white gastrocnemius muscles. Interestingly, concentrations of labelled 20:3n-6 
in various muscle types were markedly lower (up to 10 fold) than that of labelled 20:4n-6.  
Conversely, in previous human (McCloy et al., 2004) and animal (Lin and Salem, Jr., 2007) 
studies, concentrations of labelled 20:4n-6 derived from labelled linoleate was always dominated 
by that of 20:3n-6 in the circulation consistent with the sequence of metabolic reactions. The 
reported enrichment patterns (i.e. ~ 10-fold higher amount of 20:3n-6 than 20:4n-6) of the n-6 
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metabolites in the plasma (McCloy et al., 2004) which were opposite to what was found in our 
study in the muscles, have led us to believe that the primary accretion mechanism for the labelled 
20:3n-6 and 20:4n-6 has been through local metabolism of the labelled linoleate inside muscle 
rather than the uptake of the preformed molecules from circulation. After cloning of human Δ6 
desaturase (rate-limiting enzyme in catalyzing the conversion of 18:2n-6 into 20:3n-6 and 20:4n-
6), cDNA northern analysis revealed that it is expressed not only in liver but in a variety of 
human tissues including muscle (Cho, Nakamura, and Clarke, 1999). To our knowledge, there 
has not been a study to compare the activity or the expression of Δ6 desaturase enzyme in various 
muscles types. Alternatively, incorporation of 20:3n-6 and 20:4n-6 into specific PL and other 
lipid classes may be affected by the endogenous pools of these lipid classes and the turnover 
kinetics for these PUFAs in each specific muscle. 
An in vitro study of cultured lung fibroblasts using 
14
C-labelled fatty acids showed that 
20:3n-6 and 20:4n-6 were incorporated differentially into various PL species, with 20:3n-6 
enriched in phosphatidylethanolamine and phosphatidylglycerol, and 20:4n-6 enriched in 
phosphatidylcholine (Weithmann, Peterson, and Sevanian, 1989). Similarly in rat liver 
microsomes, 20:3n-6 was incorporated mainly into phosphatidylcholine, 
phosphatidylethanolamine, and phosphatidylinositol, and 20:4n-6 occurred primarily in 
phosphatidylinositol (Garda et al., 1997; Shimada, Morita, and Sugiyama, 2003). However, there 
has been yet a study to explore the differential incorporation of PUFAs in specific PL classes in 
muscle tissue. It has been demonstrated that in both the SR and mitochondria, phospholipids 
consist of approximately 80% of total lipids, with phosphatidylcholine and 
phosphatidylethanolamine making up to70-75% of the PL fraction (Fiehn et al., 1971).  
Considering the differential incorporation of PUFAs into phosphatidylethanolamine and 
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phosphatidylcholine, differences in PUFAs distribution, incorporation and metabolism among 
muscle types with varying degree of SR and mitochondrial content is probable.  
Despite the dramatic disparities in the distribution of labelled n-6 metabolites among the 
examined skeletal muscle types, fatty acid composition results from our study and previous 
studies (Blackard et al., 1997; Gorski, Nawrocki, and Murthy, 1998; Kriketos et al., 1995; 
Nikolaidis, Petridou, and Mougios, 2006) showed similar concentrations of 20:3n-6 and 20:4n-6 
among soleus, red and white gastrocnemius. The distribution pattern of the labelled n-3 was 
somewhat different from the labelled n-3 precursor.  Red gastrocnemius was the main repository 
compartment for the labelled 20:5n-3 while soleus was for that of labelled 22:6n-3.  
Unexpectedly, soleus was free from labelled 20:5n-3 and no detectable levels of labelled 22:6n-3 
was found in white gastrocnemius. Labelled 20:4n-6 was also missing from white gastrocnemius. 
Similar to the n-6 metabolites, results from Cunnane (McCloy et al., 2004) and Salem (Lin and 
Salem, Jr., 2007) have led us to believe that the primary mechanism for the accumulation of the 
labelled n-3 metabolites in the examined skeletal muscle was the intramuscular metabolism of 
the labelled 18:3n-3. In regard to the endogenous concentrations of 20:5n-3 and 22:6n-3 in the 
muscle types, soleus and red gastrocnemius had similar concentration which in turn were 
significantly higher than that of white gastrocnemius. Heart muscle behaved very similar to red 
and white gastrocnemius in regards to accumulating both n-3 and n-6 metabolites. Heart results 
were in complete agreement with the literature (Lin and Salem, Jr., 2007).  
6.2.3 Fibre type-specific distribution of labelled palmitate and oleate 
The net concentration of labelled palmitate was significantly elevated in soleus as 
compared to red and white gastrocnemius. Soleus content of labelled oleate was also greater (up 





H2-18:1n-9 determinations, the difference between muscle types was not found to be 
significant. However, the labelled palmitate and oleate accretion in various muscle types closely 
agree with that of their endogenous pool size. The endogenous pool of 16:0 in soleus, although 
statistically significant, was only slightly higher from that of red and white gastrocnemius 
muscle. In comparison, the concentrations of unlabelled 18:1n-9 in soleus were ~ 5-fold higher 
from that of gastrocnemius muscles. 
6.3 Changes in PUFAs Distribution Pattern as the Function of Time 
Distinct and somewhat predictable distribution patterns emerged for the labelled PUFA 
precursors versus labelled PUFA metabolites. While the abundance of the labelled precursors, in 
all muscle types, gradually declined over the course of the study, the isotopic signal of the 





occurred at 8 hr in all muscle types and it decayed thereafter. However, labelled 18:3n-3 
disappeared faster than labelled 18:2n-6, particularly in the red gastrocnemius and heart muscles. 
The maximal concentration of deuterated 18:2n-6 observed in plasma, skeletal muscles and heart 
is at 8 h, while for 18:3n-3 maximal concentrations have been observed at 4 hour in plasma and 8 
h in heart and liver (Lin and Salem, Jr., 2007). Similar to our results, the 18:2n-6 and 18:3n-3 
concentrations began to decay immediately after their peak with a faster rate for 18:3n-3 
compared to 18:2n-6. Time to peak enrichment has been shown to be significantly shorter for 
13
C 
18:3n-3 (6 h) than for the 
13
C 18:2n-6 (8-10 h) (McCloy et al., 2004). The decay curve for 
13
C in 
plasma total lipids occurred immediately after peak concentrations and was exponential, with 
13
C 
18:2n-6 having ~4-fold longer half-life than that of 18:3n-3. Appearance and disappearance rates 
were similar across the muscle types, therefore the rank order of labelled 18:2n-6 and 18:3n-3 
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concentrations in muscle types remained intact across time (i.e. soleus > red gastrocnemius = 
white gastrocnemius = heart).  
According to the metabolic sequence of reactions, the intermediate n-6 (20:3n-6) and n-3 
(20:5n-3) metabolites appeared in various tissues as early as 4 h post dosing and peaked at 24-96 
h (Lin and Salem, Jr., 2007). However the major in vivo n-6 (20:4n-6) and n-3 (22:6n-3) 
metabolites were first detected at 24 h and were still increasing at the last time point studied (e.g. 
600 h). Our results concerning the appearance and disappearance pattern of labelled 20:3n-6 is in 
accordance with the previously published results and there is no change in the rank order of the 
muscle types as a function of time. Although soleus and red gastrocnemius were rapidly labelled 
with a large concentration of 20:4n-6 at 8 h, this long chain n-6 PUFA was completely 
eliminated from red gastrocnemius thereafter, while it reached a higher concentration in soleus at 
48 h subsequent to a decline at 24h. Similar changes have been reported in a mixed muscle 
sample (Lin and Salem, Jr., 2007). High concentrations of deuterium labelled n-6 metabolites 
observed at 4 and 8 h time points decreased to half of their concentrations by 24 h, but at 96 h the 
concentrations began to rise and reached their maximum at 360 h (Lin and Salem, Jr., 2007). 
Labelled 22:6n-3 accumulation also varied across the muscle types over the examined time 
points.  Soleus accumulated labelled 22:6n-3 to the highest concentration at 8 h as compared 
with red gastrocnemius and heart.  Labelled 22:6n-3 was no longer detectable in soleus at 24 and 
48 h, but increasing 22:6n-3 concentrations were detected in red gastrocnemius and heart. 
Previous results in mixed muscle samples also indicate a pattern of substantial accumulation of 
labelled n-3 metabolites in the initial period (4 and 8 h) followed by a decline at 24 h and 
increasing accumulation at 96 h to a maximal concentration at 600 h (Lin and Salem, Jr., 2007).  
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Although the mechanism for appearance and disappearance patterns among various 
muscle types is not clear, the close agreement of between our results with previous results (Lin 
and Salem, Jr., 2007) in the heart muscle strongly suggests that our results are accurate measures 
of PUFA accumulation in specific muscle types. 
6.4 Efficacy of Deuterium-and Carbon-13 isotopes  
Our results concerning the quantitative recovery of 
13
C-labelled linoleate among various 
rat skeletal muscle types agree with previous stable isotope studies (Lin and Salem, Jr., 2007; 
McCloy et al., 2004). The amount of 
13
C18-18:2n-6 NEFA/EE tracers detected in soleus, red and 
white gastrocnemius ranging from 15 to 124 nmol/g of muscle were in close agreement with that 
of 
2
H5-18:2n-6 EE found in heart muscle (~ 65 nmol/g of tissue) 8 h post dose (Lin and Salem, 
Jr., 2007). Previously, fatty acid profiles of heart muscle was found to be comparable to that of 
soleus (Nikolaidis, Petridou, and Mougios, 2006) with the linoleate content of heart and soleus 
determined as 24 ±8 versus 28 ±4 mol % in triacylglycerol fraction and 47 ± 2 versus 34±2 mol 
% in phospholipid fraction, respectively. 
Unexpectedly, a lower amount of 
2
H-labelled linoleate was measured in all muscle fibres 
compared to that labelled with 
13
C, however the difference only reached significance when the 




H tracer accumulated in soleus muscle. In contrast, 
it has been reported that the endogenous pools of fatty acids have a greater suppressing effect on 
the measurements of 
13
C-labelled linoleate relative to that labelled with 
2
H (Lin, Pawlosky, and 
Salem, Jr., 2005). It is assumed that the reduced 
2
H signal in the present study is attributable to 
either the novel PCI quadrupole ion trap GC/MS technique which yet to be evaluated with this 
regard or simply a lower dose of 
2
H tracer which may have been resulted from imprecision at the 
time of dosing. Nonetheless, the results from 
2





labelled linoleate in uncovering the fibre type differences in linoleate uptake and metabolism 
supporting the main objective of this study. 
6.5 Efficacy of the Novel PCI GC-MS  
The internal isobutane PCI technique was developed to minimize parent ion 
fragmentation, increase sensitivity, produce linear responses, and allow simple sample 
preparation. Fragmentation of all FAMEs was reduced compared to either EI or methane PCI.  
The methane and isobutane PCI methods did not differ much in the profiles of saturated FAMEs, 
but in isobutane PCI, all unsaturated FAMEs were significantly less fragmented, and all FAMEs 
showed some level of intact parent ion. As yet, no published work has documented the use of 
isobutane PCI for isotopic FAME analysis in a quadrupole ion trap. In most of the tracer studies 
referenced in this document (Lin, Pawlosky, and Salem, Jr., 2005; Lin and Salem, Jr., 2007), 
methane NCI analysis of the PFB ester fatty acids via the transmission quadrupole GC-MS 
system was employed for measuring stable fatty acid isotopes. However our experiments on NCI 
method using methane as the reagent gas have led us to believe that methane NCI may not be the 
most suitable method for measuring isotopic signal, especially in quadrupole ion trap systems. 
Our results gathered using the novel PCI method are in a close range with the previously 
published results using methane NCI in rat models with comparisons to the accretion of labelled 
18:2n-6 and 18:3n-3 in heart tissue as validation. For instance the net accumulation of labelled 
18:2n-6 and 18:3n-3 in heart tissue, documented in the MESSI study, were in the range of 20-40 
and 5-20 nmol/g of tissue, respectively, while those reported previously (Lin and Salem, Jr., 
2007) were in the range of 35-65 and 10-25 nmol/g of tissue. Similar doses of these isotopic fatty 
acids were administered in both studies. 
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6.6 Study Limitations  
The major shortcoming in our studies and other studies investigating in vivo disparities in 
fibre type functional, metabolic and structural characteristics is the lack of muscle groups with 
pure fibre type make up. Individual muscles contain different fibre types that include hybrid 
fibres (the coexistence of different MHC isoforms in a single fibre) to meet the specific demands 
of the specific muscle.  Therefore observations in individual muscles may not necessarily be 
attributed to specific fibre types.  In addition there were limitations related to the quantification 









H5 22:6n-3 which match in vivo metabolites of the labelled n-6 and n-3 precursors are not 
available. Therefore the calibration curves for the labelled metabolites were made using 
unlabelled standards, supported by previous work (Lin, Pawlosky, and Salem, Jr., 2005).  
Responses for 20:3n-6 and 20:5n-3 are slightly different than that of 20:4n-6 and 22:6n-3, 
respectively, and those of labelled FAMEs are different than unlabelled FAMEs. It is therefore 
likely that n-6 metabolite enrichments reported in this study are not entirely accurate. Finally, 
despite the markedly reduced FAME fragmentation under internal isobutane PCI, fragmentation 
increases as the degree of polyunsaturation increases.  The reason for this is that the ionization of 
these HUFAs requires much lower energies than can be sustained by more unsaturated FAMEs. 
In particular, fragmentation dramatically increases in fatty acids with >3 carbon-carbon, double 
bonds.  Therefore, some HUFAs such as 20:4n-6, 20:5n-3 and 22:6n-3 must be quantified by 
high mass fragments rather than parent ions.  Further methodological developments that result in 
higher percentages of HUFA parent ions are desirable to improve sensitivity. 
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6.7 Future Directions  
Long term tracer studies have shown that muscle is labelled rapidly with n-3 and n-6 
metabolites (22:6n-3 and 20:4n-6) by the first day and eventually becomes the largest pool of 
these metabolites partially due to a large relative tissue mass (Lin and Salem, Jr., 2007). 
According to these findings, future studies on uptake, incorporation and maintenance of AA and 
DHA in specific muscle types should be explored in longer duration studies and with 
administration of the preformed labelled AA and DHA rather than their corresponding 
precursors. The results from this study can enhance and extend our current understanding of the 
fibre type-specific handling of longer chain PUFAs and it will be the first step towards 
elucidating potential fibre type specific requirements for AA and DHA. 
The β-oxidation rates of the isotopic labelled 18:2n-6 and 22:6n-3 are dramatically 
reduced in the n-6 and n-3 deficient rats, respectively, compared to control rats (Cunnane and 
Anderson, 1997a; Waki et al., 2004). These findings imply a remarkable increase in the retention 
of labelled fatty acids in the whole body compared with animals provided with PUFA adequate 
diets. Therefore a second potential future project is experimentation on n-6 and n-3 deficient rats 
which are perhaps better candidates for tracking isotopic PUFAs in the specific muscle types. 
With the new advances in the GC-MS quadrupole ion trap analysing capability, there is a 
growing interest in using hybrid configuration as compared to those of internal and external. 
Hybrid configuration is a new ionization technique specific to quadrupole ion trap GC-MS 
systems which combines the valuable features of external and internal ionization with removal of 
the critical issues for both. As of yet no study has attempted to use hybrid configuration in 
measuring stable isotopic fatty acids. Application of the hybrid configuration in ionizing FAMEs  
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appears to be a promising alternative for the current internal PCI method. These methodologies 
could also be utilized in human studies.  
6.8 Conclusions 
To date this was the first attempt to systematically compare PUFA uptake, distribution 
and metabolism among various skeletal muscle types with different fibre types after 
administration of an acute, single oral bolus of labelled n-6 and n-3 precursors. Using a battery of 
tracer studies it was revealed that soleus muscle (high type I fibres in rats), was labelled with 
significantly higher concentrations of uniformly labelled carbon 13-18:2n-6, deuterium labelled 
18:3n-3 as compared with those in red gastrocnemius and white gastrocnemius which were 
similar. Similar rank order was also observed for carbon-13 labelled n-6 metabolites derived 
from uniformly labelled carbon-13-18:2n-6. The close agreement between the results from tracer 
studies with those from comparison of the endogenous pool of PUFAs in the examined muscle 
types demonstrate that muscle type differences in PUFA handling is important and PUFA 
requirements may differ between muscle types, possibly due to functional and/or structural 
diversity among different fibre types. Finally the PCI quadrupole ion trap GC/MS technique 
using isobutane as reagent gas is useful for tracer studies in quantitatively small samples. This 
technique offers the distinct advantages of simple derivitization of fatty acid and low 




Table 5. Concentration of fatty acids in soleus, red gastrocnemius and white gastrocnemius 





 Concentration (μmol/g of tissue) 
10:0 n.d. 0.19  0.06 n.d. n.d. 
12:0 0.04  0.01
 b
 0.65  0.15 
a
 0.01  0.01 
b
 0.03  0.02 
b
 
14:0 0.30  0.01
 b
 1.05  0.19 
a
 0.20  0.03 
b
 0.24  0.05 
b
 
16:0 7.38  0.54
 ab
 8.13  0.71 
a
 5.51  0.38 
b
 6.23  0.26 
b
 
16:0 dma 0.08  0.00
 a
 0.21  0.07 
ab
 0.32  0.08 
b
 0.18 .0.04 
ab
 
18:0 10.92  0.22
 c
 5.68  0.19 
a
 5.04  0.30 
a
 3.26  0.16 
b
 
18:0 dma 0.12  0.02
 a
 0.02  0.00 
b
 0.08  0.02 
ab
 0.05  0.01 
ab
 
20:0 0.14  0.01
 a
 0.06  0.01 
b
 0.03  0.01 
c
 0.02  0.01 
d
 
22:0 0.10  0.00
 a
 0.06  0.01 
b
 0.04  0.01 
c
 0.02  0.01 
d
 
24:0 0.08  0.00
 a
 0.06  0.01 
b
 0.05  0.01 
b
 0.03  0.01 
c
 
Total SFA 19.17  0.72
 a
 16.11  1.39 
a
 11.29  0.82 
b
 10.06  0.55 
b
 
14:1 0.10  0.01
 a
 0.05 0.02 
a
 0.07  0.01 
a
 0.09  0.02 
a
 
16:1 0.11  0.02
 b
 0.73  0.14 
a
 0.09  0.01 
b
 0.12 .0.02 
b
 
18:1n-9 3.39  0.78
 ab
 5.54  0.79 
a
 1.77  0.16 
b
 1.80  0.16 
b
 
18:1n-7 1.68  0.17
 a
 1.10  0.07 
c
 0.79  0.07 
b
 0.72  0.03 
b
 
Total MUFA 5.45  0.99
 ab
 7.59  1.04 
a
 2.85  0.28 
b
 2.80  0.24 
b
 
18:2n-6 7.93  0.82
 ab
 11.15  1.37 
a
 5.87  0.51 
b
 5.09  0.29 
b
 
18:3n-6 0.01  0.00
 b
 0.06  0.01 
a
 0.03  0.01 
b
 0.02  0.01 
b
 
20:2n-6 0.17  0.01
 a
 0.18  0.01 
a
 0.15  0.01 
a
 0.15  0.01 
a
 
20:3n-6 0.17  0.01
 a
 0.23  0.01 
a
 0.20  0.16 
a
 0.22  0.01 
a
 
20:4n-6 8.65  0.74
 a
 4.27  0.18 
b
 3.94  0.30 
b
 3.54  0.17 
b
 
22:4n-6 0.66  0.06
 a
 0.40  0.01 
b
 0.35  0.03 
b
 0.37  0.02 
b
 
22:5n-6 0.71  0.03
 a
 0.34  0.01 
b
 0.35  0.02 
b
 0.27  0.01 
c
 
Total n-6 PUFA 18.31  1.66
 a
 16.63  1.62 
a
 10.88  0.89 
b
 9.66  0.50 
b
 
18:3n-3 0.19  0.02
 a
 0.61  0.11 
a
 0.10  0.01 
b
 0.11  0.01 
b
 
20:5n-3 0.05  0.00
 a
 0.07 0.01 
bc
 0.06  0.01 
ab
 0.09  0.01 
cd
 
22:5n-3 1.23  0.10
 a
 0.78  0.03 
b
 0.81  0.07 
b
 0.63  0.04 
b
 
22:6n-3 3.77  0.26
 a
 2.30  0.06 
b
 2.38  0.18 
b
 1.32  0.07 
c
 
Total n-3 PUFA 5.24  0.38
 a
 3.76  0.21 
b
 3.35  0.26 
b
 2.14  0.13 
c
 
Total PUFA 23.54  2.03
 a
 20.38  1.83 
a
 14.24  1.15 
b
 11.80  0.64 
b
 
Total HUFA 15.23  1.19
 a
 8.39  0.33 
b
 8.09  0.61 
b
 6.43  0.32 
b
 
N-6/N-3 3.81  0.27
 a
 4.43  0.32 
b
 3.25  0.87 
a
 4.51  0.54 
b
 
Total fatty acids  48.15  3.71
 a
 44.08  4.27 
a
 28.37  2.25 
b
 24.67  1.43 
b
 
Values are means ± SEM; n = 8. Values in a row not sharing a roman superscript are significantly different at P < 
0.05 by Tukey’s honestly significantly difference test after a significant F-value (P < 0.05) by one way ANOVA. 
SFA, saturated fatty acids; MUFA, monounsaturated fatty acids; PUFA, polyunsaturated fatty acids  
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Table 6. Molar percentage of fatty acids in soleus, red gastrocnemius and white gastrocnemius.  





 (Molar % of total fatty acids) 
10:0 n.d. 0.39  0.11 n.d. n.d. 
12:0 0.09  0.01
 a
 1.37  0.25 
b
 0.04  0.01 
a
 0.21  0.06 
a
 
14:0 0.64  0.05
 a
 2.30  0.28 
b
 0.75  0.13 
a
 0.98  0.19 
a
 
16:0 15.36  0.20
 a
 18.46  0.23 
b
 19.48  0.39 
b
 25.16  0.19 
c
 
16:0 dma 0.17  0.02
 a
 0.59  0.18 
a
 1.02  0.22 
b
 0.73  0.16 
a
 
18:0 23.10  1.54
 a
 13.36  0.99 
b
 17.91  0.56 
c
 13.37  0.33 
b
 
18:0 dma 0.24  0.02
 a
 n.d. 0.27 .0.07 
b
 0.21  0.14 
b
 
20:0 0.31  0.00
 a
 0.17  0.02 
b
 0.13  0.02 
b
 0.06  0.01 
c
 
22:0 0.23  0.02
 a
 0.13  0.01 
b
 0.12  0.01 
b
 0.07  0.01 
c
 
24:0 0.17  0.02
 ab
 0.13  0.01 
a
 0.18  0.02 
b
 0.12  0.01 
a
 
Total SFA 40.28  1.71
 ab
 36.64  0.66 
a
 40.10  0.88 
ab
 41.38  0.62 
b
 
14:1 0.20  0.02
 a
 0.13  0.05 
a
 0.25 0.06 
a
 0.21  0.07 
a
 
16:1 0.22  0.02
 a
 1.58  0.20 
b
 0.30  0.06 
a
 0.50  0.04 
a
 
18:1n-9 6.73  1.11
 a
 12.25  0.78 
b
 6.23  0.27 
a
 7.23  1.00 
a
 
18:1n-7 3.47  0.10
 a
 2.25  0.10 
b
 2.75  0.07 
bc
 2.90  0.51 
c
 
20:1n-9 0.13  0.13
 a
 0.18  0.02 
a
 0.14  0.02 
a
 0.13  0.01 
a
 
Total MUFA 10.96  1.22
 a
 16.91  0.83 
b
 10.02  0.35 
a
 11.44  0.43 
a
 
18:2n-6 16.36  0.60
 a
 24.86  1.02 
b
 20.53  0.52 
c
 20.37  0.40 
c
 
18:3n-6 0.02  0.00
 a
 0.13  0.02 
b
 0.09  0.01 
c
 0.07  0.01 
c
 
20:2n-6 0.35  0.01
 a
 0.41  0.01 
b
 0.54  0.01 
c
 0.59  0.02 
d
 
20:3n-6 0.35  0.01
 a
 0.52  0.02 
b
 0.70  0.01 
c
 0.99  0.09 
d
 
20:4n-6 17.79  0.21
 a
 10.02  0.71 
b
 13.85  0.14 
c
 14.35  0.54 
c
 
22:4n-6 1.36  0.02
 a
 0.94  0.06 
b
 1.26  0.08 
a
 1.50  0.05 
a
 
22:5n-6 1.48  0.05
 a
 0.80  0.08 
b
 1.24  0.05 
ac
 1.10  0.07 
c
 
Total n-6 PUFA 37.87  0.77
 a
 37.69  0.36 
a
 38.20  0.59 
a
 38.54  0.60 
a
 
18:3n-3 0.39  0.02
 a
 1.33  0.13 
b
 0.36  0.02 
a
 0.44  0.04 
a
 
20:5n-3 0.10  0.00
 a
 0.16  0.01 
b
 0.23  0.01 
c
 0.33  0.01 
d
 
22:5n-3 2.56  0.06
 a
 1.83  0.14 
b
 2.83  0.06 
a
 2.46  0.10 
a
 
22:6n-3 7.84  0.18
 a
 5.43  0.44 
b
 8.38  0.10 
a
 5.34  0.22 
b
 
Total n-3 PUFA 10.89  0.21
 a
 8.75  0.44 
b
 11.83  0.15 
a
 8.45  0.31 
b
 
Total PUFA 48.76  0.61
 ab
 46.45  0.49 
a
 50.03  0.67 
b
 46.99  0.86 
a
 
Total HUFA 31.62  0.18
 a
 19.70  1.42 
b
 28.48  0.27 
ac
 25.37  0.90
 c
 
N-6/N-3 3.50  0.15
 a
 4.38  0.24 
b
 3.23  0.05 
a
 4.60  0.13 
b
 
Values are means ± SEM; n = 8. Values in a row not sharing a roman superscript are significantly different at P < 
0.05 by Tukey’s honestly significantly difference test after a significant F-value (P < 0.05) by one-way ANOVA. 
SFA, saturated fatty acids; MUFA, monounsaturated fatty acids; PUFA, polyunsaturated fatty acids 
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Table 7. Accumulation of labelled 18:2n-6, 20:3n-6 and 20:4n-6 in various muscle types as a 
percentage of total precursor dose.   



















Soleus 0.098  0.021 0.025 0.002 0.0002 0.0003 0.002 0.001 
Red G. 0.324  0.022 0.028 0.005 0.0002 0.0002 n.d. n.d. 
White G. 0.275  0.013 0.017 0.002 n.d. n.d. n.d. n.d. 
Values are expressed as mean, n=4. 
13
C18-EE, ethyl ester form of 
13
C-labelled fatty acid; 
13
C18-NEFA, nonesterified 
fatty acid form of 
13
C-labelled fatty acid; 
2
H5-EE; ethyl ester form of 
2
H-labelled fatty acid. Red G, red 




Table 8. Comparison of net accumulation and enrichment of major n-6 metabolites in rat skeletal 
muscles 8 h after dosing with labelled 18:2n-6.  
Fatty acid Isotope 
Soleus  Red Gastrocnemius 
nmol/g % endogenous pool   nmol/g % endogenous pool 
20:3n-6 
13
C18 EE 1.21  0.29 0.53  0.13  0.26  0.07 0.13  0.03 
13
C18 FFA 1.65  0.14 0.72  0.06  0.32  0.03 0.16  0.01 
       
20:4n-6 
13
C18 EE 7.82  0.49 0.18  0.01  n.d. n.d.  
13
C18 FFA 8.65  0.3 0.20  0.01   n.d.  n.d.  
Values are means ± SEM for 4 rats in units of nmol / g of tissue. Tr; trace amount of the metabolite was detected 8 h 
after dosing with the labelled 18:2n-6; n.d., not detected. 
13
C18 EE, ethyl ester form of uniformly labelled carbon 13; 
13





Figure 6. Comparison of isotope-labelled linoleate in soleus, red gastrocnemius and white 
gastrocnemius muscles. Data are expressed as means ± SEM at 8 h after oral dosing; n = 4. A) 
Net accumulation of the labelled linoleate in nmol/g of muscle B) Muscle enrichment with 
labelled linoleate expressed as percentage of endogenous pool of linoleate. Two-way ANOVA 
analysis of the means revealed a significant interaction for the net accumulation and enrichment 
data (P = 0.03). Individual means were compared using Tukey’s honestly significantly difference 
test across various muscle types. Significant differences are denoted by different lowercase 





Figure 7. Time-course plots of the concentrations (nmol/g tissue) of 
13
C18-18:2n-6 in various 
muscle types over 2 days period following a single oral dosing. Values are mean ± SEM, n=5. 
Two-way ANOVA analysis of the means revealed no interaction (P = 0.72), and no main effect 
of time (P = 0.10). A significant main effect for muscle type was detected (P < 0.0001). 
Individual means were compared using Tukey’s honestly significantly difference test across 
various muscle types. Significantly different muscle types are denoted by different lowercase 





Figure 8. Time-course plots of the concentrations (nmol/g tissue) of 
13
C18-20:3n-6 in various 
muscle types over 2 days following a single oral dosing. Values are mean ± SEM, n=5. Two-way 
ANOVA analysis of the means revealed no interaction (P = 0.37) and no main effect for time (P 
= 0.06). A significant main effect for muscle type was detected (P < 0.0001). Individual means 
were compared using Tukey’s honestly significantly difference test across various muscle types. 






Figure 9.Time-course plots of the concentrations (nmol/g tissue) of 
13
C18-20:4n-6 in various 
muscle types over 2 days following a single oral dosing. Values are mean ± SEM, n=5. Two-way 
ANOVA analysis of the means revealed a significant interaction (P < 0.0001). However, there 
were no differences between individual means by Tukey’s honestly significant difference test. 





Figure 10. Time-course plots of the concentrations (nmol/g tissue) of 
2
H5-18:3n-3 in various 
muscle types over 2 days following a single oral dosing. Values are mean ± SEM, n=5. Two-way 
ANOVA analysis of the means revealed a significant interaction (P = 0.006). Tukey’s honestly 
significantly difference test was used to determine the significant differences in concentration of 
2
H5-18:3n-3 among various muscle types at different time points. Graph bars not sharing the 






Figure 11.Time-course plots of the concentrations (nmol/g tissue) of 
2
H5-20:5n-3 in various 
muscle types over 2 days following a single oral dosing. Values are mean ± SEM, n=5. Two-way 
ANOVA analysis of the means revealed a significant interaction (P = 0.001). Tukey’s honestly 
significant difference test was used to determine the significant differences in concentration of 
2
H5-20:5n-3 among various muscle types at different time points. Graph bars not sharing the 






Figure 12.Time-course plots of the concentrations (nmol/g tissue) of 
2
H5-22:6n-3 in various 
muscle types over 2 days following a single oral dosing. Values are mean ± SEM, n=5. Two-way 
ANOVA analysis of the means revealed a significant interaction (P = 0.04). However, there were 
no differences between individual means by Tukey’s honestly significant difference test. P < 






Figure 13.Time-course plots of the concentrations (nmol/g tissue) of 
2
H2-18:1n-9 in various 
muscle types over 2 days following a single oral dosing. Values are mean ± SEM, n=5. Two-way 
ANOVA analysis of the means revealed no interaction (P = 0.99) and there was also no main 






Figure 14.Time-course plots of the concentrations (nmol/g tissue) of 
13
C16-16:0 in various 
muscle types over 2 days following a single oral dosing. Values are mean ± SEM, n=5. Two-way 
ANOVA analysis of the means revealed no interaction (P = 0.13), and no main effect of time (P 
= 0.70). However, there was a significant main effect for muscle type (P < 0.0001). Individual 
means were compared using Tukey’s honestly significantly difference test across various muscle 














TG, PL and NEFA fractions in various muscle types. TG; triglycerols, PL; phospholipids, 
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